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The purpose of this study was to determine the effects Bifidobacterium infantis 35624 (B. 
infantis35624) has on exercise performance, inflammation/immune function, and cognitive 
outlook during a six week exercise training phase in collegiate female swimmers.  Using a two-
group matched, double-blind, placebo-controlled design, seventeen NCAA Division 1 female 
swimmers were assigned to either group and supplemented daily for six weeks a 1 x 109 CFU 
dosage of  B. infantis35624 (n=8) or placebo (n=9).  Both groups underwent an intensive six 
week swim and resistance training program.  Exercise testing (aerobic/anaerobic swim time trials 
and force plate vertical jump) as well as serum and salivary samples (cytokine and 
gastrointestinal (GI) inflammatory and immune markers) were collected pre, mid (week 3), and 
post (week 6).  Recovery-stress questionnaire for athletes (RESTQ-Sport) was administered at 
baseline and at the end of each training week.  Study data was analyzed by Analysis of 
Covariance (ANCOVA) by time point design with the respective baseline values of each 
dependent variable being the covariate.  The B. infantis35624 group had a significant reduction 
in the anti-inflammatory marker IL-1ra (p = 0.029, ηp2 = .296) and a noted statistical trend for a 
decrease in salivary IgA (p = 0.060, ηp2 = .231) in comparison to placebo at mid-point.  The B. 
infantis35624 group had significantly higher RESTQ-sport values in the sport recovery than the 
placebo group.  B. infantis35624 in Division 1 female swimmers does not directly influence 
exercise performance, but did influence markers of inflammation/immune function as well as 
cognitive outlook during six weeks of exercise training.      
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Chapter 1: Introduction 
The relentless pursuit to improve exercise performance by athletes, coaches, exercise 
scientists, and sport dietitians has brought about extensive evaluation and understanding on the 
importance of proper nutrition.  Fundamental aims for practicing sound nutrition are to promote 
good health, durability (i.e. decreased susceptibility to illness and/or injury) throughout 
intensified exercise training, enhance exercise training benefits (ex. power, speed, endurance, 
and recovery), and better optimize exercise performance.  A nutritional practice often used with 
the intent to promote these desired benefits is dietary supplementation.  One form of dietary 
supplementation known as probiotic supplementation has been attracting attention recently 
because of its effects on the gut microbiota and overall gut health [1].   
The human gut microbiota contains a diverse bacterial species understood to exert 
numerous physiological functions such as protection against pathogens, barrier effects, 
regulation of energy levels and metabolism, neutralization of drugs and carcinogens, modulation 
of intestinal motility, and regulation of immunity within the entire gastrointestinal (GI) tract [2].  
The gut microbiota is also believed to influence behavior and cognitive functions such as 
learning, memory, and decision-making [3].  Therefore, the impact on these various functions 
make it critical for the gut microbiota to exist in a state of “normobiosis”.  Normobiosis is 
defined as a state where the beneficial bacterial microorganisms outweigh harmful species in 
order to maintain overall homeostasis and health [1].  Failure to preserve normobiosis can result 
in local and systemic inflammation due to gut bacteria microorganisms producing pro-
inflammatory cytokines and stimulating an immune response [4].   
Prolonged, intensive exercise training can potentially alter gut microbiota and disrupt 
“normobiosis” [5].  Exercise training can increase the risk of common GI complaints with 
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symptoms including nausea, stomach and intestinal cramps, vomiting, and diarrhea.  These 
symptoms during exercise have been attributed to the physical up-and-down movement of the GI 
tract during running, shunting of blood flow from the GI to skeletal muscle, heart, or to the 
peripheral circulation for cooling purposes as well as thermal damage to the intestinal mucosa all 
causing intestinal barrier disruption [6, 7].  This increased permeability of the intestinal wall via 
damage to the mucosa will alter the gut microbiota, increase susceptibility to illness due to the 
absorption of antigens from microorganisms into tissue and blood stream and as a result 
stimulate an immune response, inflammation, and oxidative stress [8, 9].  
Highly trained athletes such as elite swimmers undergo periods (> 1 week) of intensive 
exercise training (i.e. overreaching) which has been reported to result in an increased 
susceptibility of upper respiratory tract infections, GI symptoms, chronic exhaustion, and overall 
reductions in sport performance [9-12].  Overreaching is defined as short-term overtraining and 
is a state of fatigue induced by a period of repetitive, high volume intense microcycles of effort 
involving concentrated workloads with inadequate periods of physical rest [13].   It is 
hypothesized these overreaching intensive training phases undertaken by athletes such as 
swimmers increase the likelihood of microtrauma (i.e. injury) to muscle, connective tissue, and 
joints [14].  Consequently, these injuries are proposed to initiate a local and “whole body” 
systemic inflammatory response that can result in suppressed immune function and alter mood 
states [14].  These altered mood states in swimmers during increased training loads have been 
monitored and reported using the Recovery-Stress Questionnaire for Athletes (RESTQ-Sport) 
developed by Kellmann and Kallus [15].  The RESTQ-Sport model measures the athlete’s 
current perceived stress and recovery in a multidimensional approach to give insight into the 
stressing agents as well as the recovery strategies being implemented to better describe the 
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interrelations of stress-states and recovery demands.  It has been reported that when a large 
exercise training load has been prescribed in swimmers (> 1 week) cognitive indicators of sport 
stress such as emotional exhaustion and injury were significantly increased while indicators of 
recovery such as physical recovery and being in shape were significantly reduced [16].           
Probiotic supplementation has demonstrated to beneficially impact the intestinal mucosal 
barrier and improve GI integrity thus, in turn, strengthening GI immune response, reducing 
mucosal inflammation, and decreasing oxidative stress [17-22].  Recent findings have shown a 
specific probiotic strain termed Bifidobacterium infantis 35624 (B. infantis 35624) to positively 
impact immune response by inducing regulatory T cells (Treg) in both animal and human models 
within the gut in addition to beyond the gut [23-25].  Specifically beyond the gut, B. infantis 
35624 supplementation has been shown to increase secretion of Treg cells in the peripheral blood 
of healthy human subjects [26].  Furthermore, 6-8 weeks of B. infantis 35624 supplementation 
has markedly decreased inflammatory biomarkers TNF-α and IL-6 in immune-inflammatory 
diseases such as chronic fatigue syndrome (CFS) patients as well as LPS stimulated peripheral 
blood mononuclear cells (PBMCs) in healthy subjects.  These systemic reductions were 
suggested to occur due to an increased number of Treg cells [23].  This effect on systemic 
inflammatory response via regulatory T cell production with B. infantis 35624 supplementation 
presents an interesting finding for athletes, such as swimmers, who participate in chronic, 
prolonged intensified exercise training resulting in potential changes in systemic inflammation, 
compromised immune function, high levels of fatigue, and periods of cognitive stress [27].  
Presently, it is not known if B. infantis 35624 supplementation in swimmers can influence 
inflammation, exercise performance, and mood states during rigorous intensive training phases 




 The purpose of this research study is to examine if chronic B. infantis 35624 
supplementation throughout an intensified six week exercise training phase influences systemic 
inflammation, exercise performance, and cognitive outlook.  
Rationale and experimental approach to the problem 
 If intensified exercise training can potentially disrupt “normobiosis” in the gut 
microbiome resulting in local (i.e. GI) and systemic inflammation then it is important to find an 
intervention capable of better controlling said inflammation from such exercise training.  Due to 
the recent findings previously discussed regarding B. infantis 35624 probiotic supplementation 
on immune and GI/systemic inflammation as well as probiotics on cognitive function it appears 
this specific strain could be an appropriate intervention for healthy athletes undergoing 
intensified exercise training. If B. infantis 35624 can positively influence exercise induced 
inflammation then it will be important to understand if there is a relationship between changes in 
gut derived systemic inflammation, whole body exercise performance, and cognitive outlook 
during the training phase. 
 To determine the effects of B. infantis 35624 on the inflammatory response, exercise 
performance, and cognitive outlook during an intensified exercise phase, a double-blind, 
randomized placebo controlled Analysis of Covariance (ANCOVA) by time point design with 
the respective baseline values of each dependent variable be the covariate was utilized.  Table 1 
illustrates the general research design and procedures.  The dependent variables for this study 
included markers of systemic inflammation, immune, and gut integrity  as well as measures of 
exercise performance (500m aerobic swim test, 100m anaerobic swim test, vertical jump force 
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plate test) and cognitive response using the Recovery-Stress Questionnaire for Athletes (RESTQ-
52 Sport).  Participants who met the inclusion criteria were randomly assigned to ingest either B. 
infantis 35624 or placebo.  Supplementation commenced at the beginning of the planned 
intensified training phase thus requiring baseline measurements which included blood samples 
and exercise performance testing to be completed at least 72 hours prior to start.  Additional 
blood samples and exercise testing to determine possible inflammation and performance 
variations during respective training phase occurred at midpoint and immediately upon 
completion of said phase. 
Independent Variables 
Subjects recruited to participate in this study were Division 1 collegiate female 
swimmers.  All subjects had a relatively similar training history at start of study since it was at 
the conclusion of their competitive season followed by two weeks of physical recovery.  They 
were instructed to ingest a daily oral encapsulated supplementation regime of either 4mg (1 
Billion count) B.infantis 35624 or 4mg of maltodextrin as the placebo throughout entire study. 
Dependent Variables 
Dependent variables included exercise performance testing, blood and salivary sampling 
to measure inflammatory and immune markers, and a cognitive stress-recovery assessment.  
Exercise performance testing occurred at three separate times (pre, mid, and post) during the 
designated supplementation and training phase.  Testing included a vertical jump force plate test 
as well as an aerobic and anaerobic swim-specific performance assessment.  The force plate was 
utilized in accordance with a standing vertical jump movement to measure rate of force 
development and explosive power.  The vertical jump test using a force plate was already being 
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conducted by the team on a monthly basis during the competitive season therefore 
familiarization was not be required.  The aerobic swim test was a 500 meter freestyle time trial 
and a anaerobic swim test consisting of a 100m prime freestyle time trial.  Each swim test was 
conducted in a 25 meter training pool located in team’s home natatorium.   Both swim tests are 
standard assessments of exercise performance frequently conducted by the team’s head coach 
during the competitive season thus the exercise performance testing did not require 
familiarization prior to experiment.  
In accordance with the exercise performance testing, blood and salivary samples were 
also obtained pre, mid, and post of the supplementation/intensified training experiment.  These 
samples provided gut inflammatory markers (LPS and LPS Binding Protein) as well as 
immunoglobulin A (IgA) and cytokine immune markers (IFN-γ, IL-1b, IL-1ra, IL-2, IL-4, IL-5, 
IL-6, IL-10, IL-13, IL-17, IL-17F, IL-22, TNF-α).   Outside the pre-supplementation baseline 
sample prior to the onset of intensified training, both mid and post blood/salivary samples were 
taken in a rested state outside of exercise training during training weeks 3 and week 6 
respectively.  Serum samples were allowed to clot at room temperature.  The serum wasthen 
separated by refrigerated centrifugation and subsequently aliquoted for immediate assay or 
frozen at -80°C for later analyses according to assay procedure requirements.  Assays included a 
13-plex cytokine panel, LPS/LBP, and salivary IgA.  These assays were performed at all blood 
collection time points previously mentioned.   
A cognitive stress-recovery assessment using the Recovery-Stress Questionnaire for 
Athletes (RESTQ-Sport) was utilized to determine the participant’s cognitive outlook throughout 
the intensified training study [15].  The primary aim for using the RESTQ-Sport was to help 
measure each supplementation group’s level of stress and recovery during the intensive training 
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experiment.  More specifically, it is additional speculative work to see if the probiotic 
supplementation could potentially influence the extent to which a participant is physically and/or 
mentally stressed which, in theory, could provide additional evidence as to why exercise 
performances might be different between the two groups.  The RESTQ-Sport was completed by 
all participants at baseline as well as at the conclusion of each training week (weeks 1-6).  
Hypotheses 
Inflammation.  Hypothesis 1:  B. infantis 35624 supplementation will effect blood markers of 
inflammation within the gut and beyond the gut as well as enhance immune function during an 
intensified exercise training phase compared to placebo. 
 
Exercise Performance.  Hypothesis 2:  B. infantis 35624 supplementation will enhance both 
aerobic and anaerobic swimming exercise performance measures as well as vertical jump force 
plate testing during an intensified exercise training phase compared to placebo. 
 
Psychological Assessment.  Hypothesis 3:  B. infantis 35624 supplementation will positively 
impact and improve measures of cognitive stress and recovery during an intensified training 
phase compared to placebo. 
Limitations and Delimitations 
 One key limitation to this research study will be the total number of subjects recruited.  
Since our subject pool will be derived from a Division 1 collegiate female swim team our total 
expected number of subjects will be approximately 20.  There are 22 female swimmers on the 
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team and we expect to lose, hopefully, only a couple due to not meeting subject inclusion criteria 
or just declining not to be a participant in the study (i.e. exiting seniors).  This sample size could 
impact our statistical power and reduce the likelihood that we will reject the null hypothesis and 
detect a statistically significant effect of B. infantis 35624 supplementation on inflammation 
markers, exercise performance, and cognitive response measures. 
 An important delimitation will be that we are not measuring exercise volume and 
intensity throughout the six week “intensified exercise training phase” to ensure an appropriate 
physical stimulus.  Rather, we are simply trusting the team’s head coach and strength & 
conditioning coach that the implemented training phase in the pool and weight room will induce 
higher levels of physical fatigue resulting in decrements of exercise performance during the 
study.   
 A second delimitation is not including additional athlete subject populations.  This is due 
to the intensified exercise training phase in both the natatorium and weight room being extremely 
specialized for Division 1 collegiate female swimmers which will require extensive 
familiarization prior to beginning of the study and not practically feasible to achieve in other 
athlete/sport populations.   
 A final delimitation made for the study is not measuring fecal excretion of B. infantis 
35624 to verify the desired changes in fecal microbiota.  Previous research using B. infantis 
35624 supplementation has been able to confirm detection of its bacterial DNA in fecal samples 
suggesting the probiotic is able to survive transit through the GI tract [28].  Therefore, to help 
keep study’s attention strictly on B. infantis 35624 effects on inflammation, exercise 
performance, and cognitive response we will refer to these previous findings in regards to the 




 We assume the team’s head coach and strength and conditioning coach are providing an 
appropriate exercise stimulus that is overreaching which should be sufficiently intensive and 
exhaustive enough to subsequently decrease exercise performance during the research study.  In 
addition, we assume the head coach and strength coach will set clear expectations on how the 
subjects are to complete each exercise training session and not permit subjects to give poor 
effort. 
 We assume the subjects will be truthful with inclusion criteria at the start of study and 
appropriately notify us if any aspects of inclusion changes anytime during the study to help 
control potential external influences on findings.  We also assume subjects are giving their best 
effort during the entire exercise study, remain truthful each week when completing the RESTQ-
Sport, and maintain a relatively normal dietary intake. 
 Finally, we are assuming the B. infantis 35624 supplement we purchase at a local retail 
store does indeed contain the 1 billion count of viable bacteria (4mg).       
        
  







Table 1 General research procedures     
 
    Week 0 Weeks 1&2   Week 3   Week 4   Week 5   Week 6 
    Baseline 8hr    8hr    8hr   20hr   20hr  
Monday 
AM   Week 1   Week 2   Week 3   Week 4   Week 5 
PM  Compliance  Compliance  Compliance  Compliance  Compliance 
Tuesday 
AM           
PM 100m Swim   100m Swim      100m Swim 
Wednesday 
AM Force Plate   Force Plate      Force Plate 
PM Blood sample   Blood sample      Blood sample 
Thursday 
AM           
PM 500m Swim   500m Swim      500m Swim 
Friday 
AM Return Logs   Return Logs      Return Logs 














Chapter 2: Literature Review 
B. Infantis 35624 
Discovery.  B. infantis 35624 was first discovered from resected healthy human gastrointestinal 
tissue approximately 20 years ago [24].  The discovery was result of a bigger project aimed to 
take healthy human gastrointestinal (GI) tissue and isolate/identify probiotic candidates that were 
populated with lactic acid bacteria.  It was hypothesized this co-occupancy of probiotic strains, 
like B. infantis 35624, with lactic acid bacteria amongst the mucosa of resected GI tissue would 
identify probiotic strains that could not only work well in the complex human GI system, but 
also have potential GI immunomodulatory effects on epithelial cells, dendritic cells, and T 
lymphocytes. 
B. Infantis 35624 Immunomodulatory Effects 
GI Transit.  Before B. infantis 35624 can begin to exert its potential GI immunomodulatory 
effects it must first survive degradation throughout the human GI tract, particularly by the gastric 
acid and bile salts in the upper GI tract.  A fecal excretion study is commonly applied to 
understand a probiotics ability to survive GI transit.  The measurement of a fecal sample’s 
microbiota during probiotic supplementation using quantitative PCR (qPCR) will provide 
recovery rates of the supplemented probiotic’s DNA as well as help gain insight on the potential 
influence probiotic supplementation is having on the composition of the GI microbiota. 
A fecal excretion study in humans has been conducted with B. infantis 35624 
supplementation by Charbonneau et al. 2013 [28].  This study was conducted by supplementing 
two groups, an irritable bowel syndrome (IBS) diseased group and a healthy group, with a 1 
billion count of oral supplemented B. infantis 35624 daily for eight weeks.  They found in both 
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groups from Week 1 to Week 4 of supplementation similar increases in fecal excretion of B. 
infantis 35624 DNA with steady state being reached between Week 4 to Week 8.  Thus, it 
appears in both a healthy and non-healthy GI, B. infantis 35624 can survive GI transit.  However, 
a limitation of this study is the PCR only detected B. infantis 35624 DNA and did not perform 
strain selective culture techniques to confirm the microbe’s viability in the feces. 
   
Epithelial Cells.  Epithelial cells are located within the GI mucosa and are the first to encounter 
microbes.  The epithelium is critical in maintaining intestinal homeostasis and does so by 
actively sampling pathogens, antigens, and resident bacteria [29, 30].   Certain microbes’ 
epithelial cells encounter will induce pro-inflammatory transcription factor expression and 
chemokine secretion.  For example, in response to pathogenic bacteria, pro-inflammatory 
cytokines such as tumour necrosis factor (TNF-α) as well as a pro-inflammatory chemokine, 
interleukin 8 (IL-8), are secreted by epithelial cells and transcriptionally regulated by nuclear 
factor (NF)-κB, a pro-inflammatory signaling pathway [31-33].   
Epithelial cells exposed to the commensal bacteria B. infantis 35624 have been 
demonstrated by O’Hara et al. 2006 to be immunologically unresponsive [34].  O’Hara et al. 
found B. infantis 35624 does not induce pro-inflammatory responses by the epithelial cells and 
instead inhibits epithelial cell secretion of the pro-inflammatory chemokine IL-8.  Moreover, 
they reported that NFκB activation via Salmonella typhimurium and subsequent IL-8 secretion 
was attenuated by B. infantis 35624.  Similar findings were observed in 2009 by Sibartie et al. 
using human intestinal epithelial cells.  Sibartie et al. reported that when exposed to several 
pathogens (i.e. Salmonella typhimurium, Clostridium difficile, Mycobacterium paratuberculosis) 
the epithelial cells activated NFκB and stimulated secretion of the pro-inflammatory chemokines 
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CCL20 and IL-8 [35].  However, when the intestinal epithelial cells were exposed to B. infantis 
35624 they did not secrete CCL20 thus limiting inflammatory signals induced by pathogenic 
bacteria.  Therefore, both O’Hara et al. and Sibartie et al. have demonstrated epithelial cells to be 
immunologically dormant when exposed to B. infantis 35624.  Furthermore, it appears B. 
infantis 35624 could elicit immunomodulatory effects on the epithelial cell’s pro-inflammatory 
response to gastrointestinal pathogens.  
 
Dendritic Cells.  Dendritic cells (DCs) are cells present in areas highly vulnerable to pathogenic 
entry such as the GI system.  They are professional antigen cells whom survey their environment 
looking for antigenic material.  Once antigenic material is located the DCs convert from 
immature sentinel cells into mature, potent effector DCs.  These mature DCs will then migrate to 
T-cell areas to activate and influence T-cell pathogen-specific cytokine expression levels [36].   
According to O’Mahony et al. 2006, DCs has a divergent cytokine response to B. infantis 
35624 in comparison to pathogenic bacteria [37].  They utilized DCs isolated from human 
mesenteric lymph node following a surgical resection of inflamed gut as a result of inflammatory 
bowel disease.  O’Mahony et al. found these DCs, in response to B. infantis 35624, stimulated 
secretions of IL-10 and TGFβ indicating a reduction in inflammation.  This finding was in stark 
contrast to the same DCs exposed to the pathogen bacteria Salmonella typhimurium which 
induced only pro-inflammatory markers IL-12 and TNFα.  Similar findings were reported by 
O’Hara et al. 2006 in which B. infantis 35624 stimulated the secretion of IL-10 and TNF-α by 
myeloid DCs [34].   Additional findings by Konieczna et al. 2012 helped confirm these divergent 
DCs cytokine specific secretions by stimulating numerous other DCs subsets with B. infantis 
35624 resulting in secretion of only IL-10 and not IL-12 [26].   
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It was reported the same year by Gad et al. 2011 that the effects of B. infantis 35624 on 
human dendritic cells were further reaching [38].  Gad et al. demonstrated the ability of B. 
infantis 35624 to actually suppress DCs derived IL-12 secretion while exposing these DCs to 
three different pro-inflammatory cocktails aimed to induce IL-12.  These suppression levels were 
stated to be comparable with 1.0 µM dexamethasone, an anti-inflammatory glucocorticoid 
known to inhibit IL-12 secretion.  They also found similar B. infantis 35624 effects on DC IL-10 
secretion, but stated the IL-10 secretion was not involved in the IL-12 suppression.  This was 
determined by adding a neutralizing anti-body toward IL-10 and still observed IL-12 suppressive 
activity in the presence of B. infantis 35624.  Thus, the current literature suggests B. infantis 
35624 can both selectively stimulate an anti-inflammatory cytokine response and suppress a pro-
inflammatory cytokine response in numerous human DCs. 
 
T Lymphocytes.  One kind of T lymphocyte known as regulatory T cells (Treg) is part of the 
immune response designated to better contain reactions and limit the aggressive spread of these 
immune responses to other tissues.  Treg cells can be induced from the gut mucosa [39].  They 
are integral in preserving tolerance to gastrointestinal microbiota and food antigens as well as 
influencing immunological reactivity to said microbiota and antigens [39-41].  These Treg cells 
within the gut mucosa are induced primarily from DCs which suggest commensal bacteria could 
influence Treg production per previous evidence of B. infantis 35624 on DCs [42].   
B. infantis 35624 in the animal model has been shown to induce Treg cells and mediate 
protection against a pathogen stimulated pro-inflammatory response [43].  O’Mahony et al. 2008 
exposed mice to either the pathogen salmonella or lipopolysaccharide (LPS) which is an 
endotoxin known to illicit a strong immune response in animals.  They found the mice fed with 
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B. infantis 35624 throughout the course of either infection significantly increased Treg cell 
production.  This B. infantis 35624 derived inductions of Treg cells in the small intestine, liver, 
and spleen of infected mice reduced the expression of the pro-inflammatory transcription factor 
NFκB.  The impact of a reduced NFκB response resulted in a reduction of pro-inflammatory 
cytokines such as TNF-α and IL-6 in the small intestine, liver, and spleen.  Therefore, it appears 
B. infantis 35624 induced Treg cells can influence pro-inflammatory pathways in response to a 
translocating pathogen.   
Additional findings by Konieczna et al. 2012 reported human DCs stimulated with B. 
infantis 35624 were shown to selectively upregulate forkhead box P3 (Foxp3) expression in 
immature lymphocytes and subsequently induce Treg cells which are vital in protecting against 
LPS or pathogen-induced NFκB activation [26].  Foxp3 is known as a master transcription factor 
critical in the development/function of Treg cells and in maintaining overall immune 
homeostasis [44].  This increased expression of Foxp3 Treg cells are found in peripheral blood 
and is associated with an increased secretion of IL-10.  These peripheral Treg cell findings by 
Konieczna et al. were later supported by Groeger et al. 2013 in both healthy humans and humans 
diagnosed with chronic fatigue syndrome (CFS) [23].  Groeger et al. found that CFS patients 
supplemented with a 10 Billion count of B. infantis 35624 supplementation daily for 6-8 weeks 
exerted significant reductions in TNF-α and marginal decreases in IL-6 levels systemically.  
Furthermore, ex vivo studies from LPS stimulated peripheral blood mononuclear cells in the 
healthy human subjects also resulted in significant reductions in IL-6 and TNF-α secretion.  
These findings suggest B. infantis 35624 supplementation in both the animal and human model 
can induce DC derived Treg cell production to provide additional immunomodulatory effects 




Neural Function – Gut-Brain Interaction.  The strong evidence demonstrating B. infantis 
35624 immunomodulatory effects within the gut and systemically beyond the gut has given way 
to research efforts aimed in understanding these effects on gut-brain interactions.  For example, 
in the animal model, it has been reported that in the absence of GI microbes there is a reduced 
expression of brain-derived neurotrophic factor within the cortex and hippocampus with an 
exaggerated hypothalamic-pituitary-adrenal axis in response to stress [45].  However, chronic 
supplementation of probiotic bacteria in rats has shown to attenuate the cytokine response under 
mitogen stimulation which is known to activate different signaling pathways in early and late-
divided T cells [46].  In addition to these cytokine reductions, probiotic supplementation has also 
been able to induce increases in peripheral concentrations of the serotonin precursor tryptophan 
[46].  Interestingly, a clinical trial conducted by Rao et al. 2009 has demonstrated an increase in 
the concentration of Bifidobacterium within the gut can reduce levels of anxiety and improve 
mood in CFS patients [47].  Therefore, these findings suggest probiotic bacteria can positively 
influence various emotional states. 
Bifidobacteria has been reported in the animal model to be vulnerable to the effects of 
emotional stress and negatively alter the composition of intestinal microbiota resulting in 
reduced concentrations of bifidobateria [48, 49].  To study the specific effects of B. infantis 
35624 on stress, Desbonnet et al. 2010 utilized the maternal separation (MS) model of depression 
in rodents [50].  Desbonnet et al. found that rodents chronically supplemented with B. infantis 
35624 had attenuated MS symptoms.  Typical MS symptoms included in this study decreased 
forced swim test performance followed by an increase in immobility during the forced swim test 
as well as exaggerated MS derived IL-6 release.  Although, these attenuations were not of the 
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same magnitude as the MS rodents treated with the anti-depressant citalopram.  Nonetheless, this 
study provides preliminary evidence suggesting chronic B. infantis 35624 supplementation in the 
MS rodent depression model can positively influence neuronal systems and behaviors pertinent 
depression.  These findings in addition to Rao et al. in CFS patients presents a potentially bigger 
role Bifidobacterium and its subspecies B. infantis 35624 can play in gut-brain interactions as 
well as suggests a prospective therapeutic application for these probiotics in response to various 
forms of stress. 
Acute Intensive Exercise (Stress) 
Pro-inflammatory Cytokine Response - TNF-α and IL-1β.  Circulating levels of pro-
inflammatory cytokines TNF-α and IL-1β have been reported to increase during and after 
exercise [51-55].  These responses have been measured in various exercise modes.  For example, 
circulating TNF-α levels significantly increased post-exercise (immediately or 2-3hr post-
exercise) in near-maximal intensity exercise under 30 minutes in duration, submaximal 
concentric exercise within 2hr in duration (ex. cycling, rowing, running), and endurance exercise 
lasting longer than 2hrs [51, 53, 56, 57].  However, numerous other studies implementing 
analogous exercise modes were unable to report similar increases in circulating TNF-α after 
exercise [58].  This inability to detect TNF-α consistently has been suggested to be attributed to 
either the exercise intensity being too low, a delayed secretion, or a rapid clearance from 
circulation into the urine since the kidney is the major organ for TNF-α clearance [59, 60].  
Furthermore, soluble TNF receptors have been shown to be stimulated by exercise which can 
also inactivate potential action of TNF-α [59]. Therefore, according to the literature, circulating 
TNF-α levels following acute exercise training can be affected by numerous mechanisms 
resulting in inconsistent systemic responses. 
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Similar to TNF-α, circulating levels of IL-1β have been demonstrated to increase in 
response to near-maximal intensity exercise under 30 minutes duration or endurance exercise 
longer than 2 hours in duration [54, 55, 61, 62].  However, the large majority of studies using 
similar exercise protocols have failed to report comparable findings [58].  Significantly increased 
circulating levels of IL-1β were predominately found to occur after long-duration exercise [55, 
61, 62].  It is believed this inability to consistently detect circulating IL-1β is due to a delayed 
secretion, short half-life (6-10 minute), lack of highly sensitive methodologies necessary to 
detect it systemic concentrations changes which occur in the pg/ml range, or its increased 
circulation remains localized in injured tissue and does not leak out systemically unless damage 
is too great [63].  Consequently, despite limited findings reporting increased circulating levels of 
the pro-inflammatory cytokines TNF-α and IL-1β in response to an acute exercise bout, it 
appears that multiple mechanisms during/immediately post-exercise as well as varying exercise 
intensities/durations are strongly influencing changes on a systemic level resulting in changes to 
occur mainly in local tissue, hence, a conflict in findings amongst the literature. 
 
Immunomodulatory Cytokine Response – IFN-γ.  Interferon gamma (IFN-γ) is an 
immunomodulatory cytokine shown in numerous studies to decrease in response to exercise [64-
68].  Reduced production of IFN-γ following exercise was observed to occur in peripheral blood 
monocytes, lymphocytes (ex. Treg cells) or whole blood.  A study by Clancy et al. 2006 found 
the secretion of IFN-γ from blood CD4 T cells measured in whole blood culture was 
significantly lower in athletes reporting fatigue in comparison to healthy controls [65].  Clancy et 
al.’s finding supports previous studies demonstrating exercise (acute and chronic) to 
downregulate IFN-γ secretion by immune cells such as lymphocytes.  It also suggests these 
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altered productions by these particular immune cells can negatively modulate immune function 
potentially increasing susceptibility to fatigue and infection. 
 
Multi-functional Cytokine Response – IL-6.  The multi-functional cytokine IL-6 has been 
reported to increase following various modes of exercise such as near-maximal exercise, 
submaximal concentric exercise less than two hours in duration, eccentric exercise, and 
endurance exercise greater than two hours in duration [51, 52, 55, 60, 69-75].  IL-6 responses to 
near-maximal exercise and submaximal concentric exercise ranged from 25% - 75% increases on 
up to 2-5 times higher circulating levels in comparison to pre values while eccentric exercise 
produced slightly greater responses ranging between 5-7.7 times higher than pre values [51, 60, 
70, 72, 73, 75].  IL-6 responses to endurance exercise, such as marathon and ultramarathon 
running, was significantly higher with ranges between 30 – 128 times higher than pre values [27, 
55, 76-78].  Circulating sources of IL-6 are typically from blood leukocytes (i.e. monocytes), the 
brain, and liver.  However, during intensive bouts of exercise, skeletal muscle has been shown to 
significantly contribute to these substantial increases [79].  Significant increases of IL-6 in 
response to exercise are transient with levels returning to baseline resting levels within an hour 
post-exercise [80].  These findings suggest IL-6’s response to exercise is driven more by 
duration rather intensity with the longer duration exercise bouts producing the higher systemic 
IL-6 circulating levels resulting in an emergency recruitment of neutrophils and subsequent 




Anti-inflammatory Cytokine Response - IL-1Ra.  IL-1Ra is an anti-inflammatory cytokine 
and is a natural antagonist that competes with IL-1β for receptor binding without initiating signal 
transduction [81, 82]. Significant elevations in IL-1Ra levels of up to 40 fold increases have been 
reported to occur following most endurance exercise [58].  However, following higher intensity 
endurance exercise, such as a marathon race, IL-1Ra levels have been reported to be 200 times 
greater than resting levels [83].  Research suggests this increase following endurance exercise is 
in response to the rapid increase of IL-6 concentrations [27, 84].  Previous studies have 
demonstrated IL-1Ra originates from mononuclear and polymorphonuclear leukocytes as 
opposed to IL-6 which is produced locally in the working muscle during exercise [77, 84, 85].  It 
is believed the production of the pro-inflammatory cytokine IL-6 within skeletal muscle is 
increased during/after exercise and capable of being released in large amounts into the 
circulation.  As a result of this systemic release of IL-6 from skeletal muscle, leukocyte derived 
IL-1Ra production is significantly increased in efforts to block the IL-1 receptor and exert strong 
anti-inflammatory effects [84, 86, 87].  Thus, it is suggested the levels of systemic IL-1Ra reflect 
the production of IL-6 [88].                         
 
Anti-inflammatory Cytokine Response – IL-10.  According to the literature, the anti-
inflammatory cytokine IL-10 has been reported to significantly increase following only 
exhaustive endurance exercise greater than two hours in duration [27, 55, 67, 76, 89].  These 
exhaustive endurance exercise bouts included completions of marathon and ultramarathon races 
resulting in IL-10 levels to be 27 – 60 times higher in comparison to pre-exercise levels.  It is 
believed these increased circulatory levels of IL-10 are in response to the transient rise in 
circulating IL-6 [90].  This association between IL-6 and IL-10 was demonstrated in a study by 
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Steensberg et al. 2003 that intravenous infused IL-6 could mimic the acute rise in IL-10 as 
observed following a bout of exercise in humans.  These increased levels of IL-10 are believed to 
be the cause of immunosuppression associated with this kind of physical trauma by attenuating 
the synthesis of cytokines such as IL-1β, TNF-α, and IL-6, resulting in an increased 
susceptibility to infection or illness [91, 92].  
 
LPS Response.  Increased concentrations of LPS in the blood have been associated with an 
acute intense bout of endurance exercise [52, 93].  LPS is a gram-negative bacterial endotoxin 
normally located within the intestine.  In normal (non-exercise) conditions, the tight junctions at 
the epithelium of the intestine are essentially impermeable to gram negative bacteria such as 
LPS.  However, undergoing intense exercise will redistribute blood supply thus reducing blood 
flow to intestinal mucosa resulting in hypoperfusion and as a result compromise the intestinal 
mucosa wall [94].  Consequently, this damage to the intestinal mucosa wall allows LPS to 
translocate into the bloodstream during intensive exercise [93].  Increased concentrations of LPS 
in the bloodstream activate inflammation by increasing production of pro-inflammatory 
cytokines such as TNF-α and IL-6.  
Exercise-induced changes in plasma LPS concentrations have been shown to be affected 
by ambient temperature (i.e. hot vs cold).  A study by Yeh et al. 2013 found in healthy subjects 
completing a 45 minute treadmill exercise at 70% VO2max in a climate chamber at either 91° F 
and 50% humidity or 77° F at 60% humidity plasma LPS concentrations were significantly 
higher in the heat with no change in the cool exercise trial [95].  However, they reported 
intestinal permeability responded similar in both hot and cool environments.  Yeh et al. suggest 
the higher LPS plasma concentrations in a hot environment are not because of a difference in 
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intestinal permeability, but instead due to a compromise in the ability to remove LPS by anti-
LPS mechanisms in the blood. 
These observed changes in plasma LPS concentrations following intensive exercise 
produce cytokines in response to this endotoxin.  A study by Abbasi et al. 2013 examined the 
effects prolonged exhaustive exercise on LPS-induced cytokine production in whole blood [96].  
Abbasi et al. used well trained men and women and had them perform an official half-marathon 
in a cool temperature environment of 33° F.  They collected whole blood samples before, 30 
minutes after, 3 h after, and 24h after the half marathon.  The cytokines included in this study 
were TNF-α, IFN-ү, and IL-10.  In regards to TNF-α, Abbasi reported no induction by the 
exercise bout, but the subject’s LPS-stimulated blood samples production of TNF-α was 
significantly lower in comparison pre-exercise levels with no difference between sexes.  Another 
pro-inflammatory cytokine, IFN-ү, also had a substantial suppression following LPS stimulation.  
Therefore, it appears these pro-inflammatory cytokine productions were significantly 
downregulated following intensive exercise.  Of particular interest was their findings with IL-10.  
They reported IL-10 to be most strongly influenced by the exhaustive exercise.  IL-10 in 
unstimulated control cultures had a significant increase 30 minutes following the run.  However, 
it was noted these exercise-induced IL-10 levels 30 minutes post-exercise were only significantly 
higher in men and not women.  In addition, under LPS-stimulation, they did not observe a 
significant increase in IL-10 production in either sex.  This finding suggests exercise induction of 
IL-10 operates through entirely different pathways and not by LPS-stimulation.  Furthermore, 
these results potentially indicate a less pronounced anti-inflammatory cytokine response in 




Treg Cells Response.  Foxp3 Treg cells has been shown in response to in vitro antigenic 
stimulation following a 12 week Tai Chi Chaun exercise program to markedly increase 
production of TGF-β and IL-10 in human peripheral blood mononuclear cells (PBMCs) [97].  In 
a mouse model study using a moderate- or high-intensity running exercise program reported that 
high-intensity training increased Treg cell numbers with subsequent reductions in pro-
inflammatory (IL-2, IFN-γ, and IL-12) and increased anti-inflammatory cytokine expression (IL-
1ra, IL-4,and IL-10) [98].  These findings suggest high-intensity exercise as well as chronic 
exercise training can mobilize and boost Treg cell production derived from lymphoid organs 
such as the spleen thus increasing anti-inflammatory cytokine secretions such as IL-10.  
Chronic Intensive Exercise  
Immune Cell Response.  Monocytes, neutrophils, and DC are functionally important immune 
cells understood to produce various inflammatory cytokines such as IL-1β, IL-6, and TNF-α in 
efforts to protect against infections.  These immune cell derived cytokines have been shown by 
Morgado et el. 2012 to be affected by chronic, prolonged intensified exercise training phases in a 
group of elite swimmers [99].  Morgado et al. obtained peripheral blood samples on four separate 
occasions throughout their intensive training season and found that chronic, long term intensive 
training significantly effects the capacity of the immune cells (i.e. monocytes, neutrophils, and 
DC) to produce inflammatory cytokines.  This was determined by measuring immune cell 
derived cytokine production following 6 hour incubation in the presence or absence of 
inflammatory stimulates LPS and IFN-γ.  That is, LPS and IFN-γ stimulation decreased immune 
cell cytokine production during the training season.  A reduction in these immune cell cytokines 




Immunoglobulin A (IgA).  IgA is a class of antibodies secreted in fluids such as saliva, tears or 
mucus from the intestines.  It is the predominant protein in the mucosal antibody response which 
is critical in helping neutralize toxins and remove pathogens [100].  However, chronic, prolonged 
intensive exercise has been shown to decrease salivary IgA levels and subsequently increase 
likelihood of developing an upper respiratory tract infection in athletes [101, 102].  This inverse 
relationship between salivary IgA and development of upper respiratory tract infection was 
demonstrated in marathon runners by Nieman et al. 2006 [103].  They found salivary IgA 
secretion was reduced by 10% with 25% of the runners reporting an upper respiratory tract 
infection within two weeks after completing the race.  It has been suggested by Steerenberg et al. 
1997 this increased susceptibility to an infection after prolonged intensive exercise could be due 
to the exposure of micro-organisms or pathogens present in the air or water in concert with a 
weakened antibody immune response [104].       
 
Cognitive Response.  Chronic intensive exercise training is utilized by competitive athletes to 
help enhance sport and/or exercise performance.  It is common for well-trained athletes to 
undergo short intensive exercise training microcycles known as “overreaching” phases to induce 
a state of fatigue as a result of concentrated exercise workloads with minimal time for adequate 
rest and recovery.  This overreaching phase is often associated with decreased exercise 
performance.  In addition to whole-body fatigue and diminished performance, cognitive response 
during an intensive overreaching phase has been reported to be negatively affected [16, 105].  
Changes in mental state (i.e. enhancement of negative moods), emotional instability, drop in 
motivation, and even depression have all been associated with overreaching or overtraining loads 
[106-110].  These alterations in cognitive outlook during chronic intensive exercise training 
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cycles are believed to be strongly influenced by non-specific immune activation and systemic 
cytokine release [14, 105, 111].   
To better understand the relationship between chronic intensive exercise training and 
cytokines, a study by Main et al. 2010 utilized elite male rowers preparing for the 2007 Rowing 
World Championships [105].  These athletes trained seven days a week which included 14 
training sessions each week resulting in a weekly training duration of 24 hours (3.4 hours/day).  
Throughout the eight week study they collected blood samples to analyze cytokine values on 4 
separate occasions in addition to a 22-item training distress assessment model.  Main et al. found 
that during the eight weeks of intensive endurance training leading up to the championships 
symptoms of overreaching were observed, but none of the athletes developed overtraining.  
Despite no statistically significant changes during the overreaching phase for any of the 
cytokines measured (IL-1β, IL-6, IL-8, IL-10, TNF-α, IL-12p70), changes in inflammatory 
cytokines on measures of training overload (i.e. training distress) discovered significant effects.  
For example, there was an association between increased measures of depressed moods and 
significant increases in 1L-1β, IL-6, and TNF-α.  Furthermore, increases in depressed moods 
were also associated with a significant decrease in IL-10.  Perceived overall stress was associated 
with a significant increase in IL-1β and TNF-α.  Finally, increase in vigor was associated with 
decreases in IL-6 and an increase in IL-10.  Therefore, these findings by Main et al. suggest a 
potential relationship between changes in systemic cytokines and cognitive response during 
chronic intensive exercise training. 
One model utilized to measure cognitive response during phases of chronic intensive 
exercise training is the Recovery-Stress Questionnaire for Athletes (RESTQ-Sport) [15].  This 
questionnaire consists of either 76 (long version) or 52 (short version) items used to assess in a 
26 
 
multidimensional way an athlete’s recovery-stress state during a specific training cycle.  Each 
item answered in the RESTQ-Sport will indicate how often an athlete participated in certain 
activities during the previous three days and nights.  These items are used to generate 19 specific 
recovery-stress scales which are grouped into four categories; general stress, general recovery, 
sport stress, and sport recovery.  The test-retest reliability of each scale in numerous sport 
research samples (ex. swimming, rowing, and track & field) using Cronbach alpha coefficients 
has demonstrated acceptable internal consistency with values slightly less or greater than 0.7 if 
repeated every 3-4 days [15, 112].  In addition, the expected relationships between each RESTQ-
Sport scale and the actual state have been empirically verified by its correlation with other 
models such as the Multidimensional Physical Symptom List, the Profile of Mood States, and the 
State-Trait-Anxiety Inventory [15].   
The RESTQ-Sport derived recovery-stress state has also demonstrated an ability to 
reflect training load.  For example, multiple RESTQ-Sport studies using samples from sports 
such as rowing, swimming, soccer, basketball, and mountain biking have reported a dose-
response relationship between the respective sport’s training volume and the subjective 
assessment of stress and recovery [15, 16].  Therefore, these findings suggest RESTQ-Sport 
provides the reliability and validity necessary to effectively observe the cognitive response of 
individual athletes and/or sport teams over periods of chronic intensive exercise training.             
Probiotic Supplementation and Athletes 
Immune Function.  According to a commentary article by Pyne et al. 2015, since 2006, 15 
experimental studies have been published investigating the effects of probiotics on athletes 
[113].  The most commonly studied probiotic species used in these probiotic and athlete studies 
was Lactobacillus [113].  The primary aims of these studies were to determine the influence 
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probiotics might have on clinical measures of illness and immune function.  For example, a study 
by Clancy et al. 2006 found in fatigued athletes with impaired athletic performances their whole-
blood culture level of IFN-γ from Treg cells was approximately half of the healthy control 
athletes thus suggesting an immune defect [65].  However, after Clancy et al. supplemented the 
fatigued athletes with a 10 Billion count of L. acidophilus daily for four weeks they found the 
fatigued athletes Treg cell derived IFN-γ secretion was restored.  This was the first study to 
report in fatigued athletes a systemic Treg cell immune defect could be reversed with probiotic 
supplementation and potentially decrease illness susceptibility.  This whole-blood IFN-γ increase 
with probiotic supplementation was supported by Cox et al. 2010 who reported that one month 
supplementation of L. fermentum (12 Billion count daily) in 20 elite male distance runners 
increased whole-blood IFN-γ secretion twofold with a 50% lower number of self-reported days 
of being ill (i.e. symptoms of upper respiratory illness) despite no statistically significant 
difference in salivary IgA [114]. 
 
GI Effects.  As previously discussed, intense strenuous exercise can disrupt the intestinal 
mucosa wall leading to a more relaxed tight junctions and increased intestinal permeability.  
Probiotic supplementation has been proposed to potentially counteract exercise-induced 
intestinal barrier dysfunction [5].  This effect was hypothesized to occur by Lamprecht et al. 
2013 which believed the supplemented probiotic population would surpass bacteria that activated 
zonulin production.  Zonulin is a protein understood to modulate the permeability of the tight 
junctions.  Increased levels of zonulin means permeability is greater.  Lamprecht et al. found 
ingestion of a multi-species probiotic supplementation (10 Billion count/day) for 14 weeks in 
trained men following a triple-step cycle ergometry exercise trial decreased zonulin levels.  
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These reductions were measured by zonulin’s presence in feces.  Therefore, this reduction in 
zonulin suggest probiotic supplementation can improve intestinal barrier integrity while 
undergoing intensive exercise.  
 
Ergogenic Effects.  There have also been findings reporting a direct ergogenic benefit in 
exercise performance from probiotic supplementation [115, 116].  One study conducted by Shing 
et al. 2014 utilized trained male runners in a single group crossover design with a 28 day 
washout period and supplemented them for 4 weeks with 45 billion of a multi-strain probiotic 
supplement that included Lactobacillus, Bifidobacterium, and Streptococcus strains.  After 4 
weeks of daily probiotic supplementation or placebo they completed a time-to-fatigue test in the 
heat.  Shing et al. found when the runners were supplemented with the probiotic their run time-
to-fatigue significantly increased with the average being 37:44 ± 2:42 vs 33:00 ±2:27 with 
placebo.  Serum LPS concentrations significantly increased between pre- and post-exercise, 
however, the probiotic supplementation was unable to significantly alter or reduce these 
increased concentrations.  Furthermore, plasma concentrations of IL-6 and IL-10 were reported 
to also increase following the time-to-fatigue exercise test, however, similar to LPS the probiotic 
supplementation was unable to effect these increased secretions.  Despite these findings, they are 
unclear on the exact mechanism(s) for this perceived direct exercise performance benefit from 
the probiotic supplementation. 
Another study by Salarki et al. 2013 studied the effects of a probiotic yogurt on exercise 
performance in young adult female endurance swimmers [115].  The probiotic yogurt contained 
several probiotic strains with a total bacteria count of 40 Billion and was consumed for 8 weeks.  
Salarki et al. found the athletes supplemented with the probiotic yogurt resulted in a significant 
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improvement in VO2max.  They suggest this observed improvement in VO2max was related to the 
reduction in the number of occurrences of respiratory infections as well as the probiotic yogurt 
fed athletes being healthier overall during the 8 weeks of training.  Though limited, these two 
studies suggest probiotic supplementation can enhance exercise performance.  However, it is 
unclear if these probiotic associated benefits are directly or indirectly related with the indirectly 
by way of enhancing immune function and reducing susceptibility to illness during chronic 
intensive exercise training thus allowing athlete to maximize training benefits.   
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The purpose of this study was to determine the effects Bifidobacterium infantis 35624 (B. 
infantis35624) has on exercise performance, inflammation/immune function, and cognitive 
outlook during a six week exercise training phase in collegiate female swimmers.  Using a two-
group matched, double-blind, placebo-controlled design, seventeen NCAA Division 1 female 
swimmers were assigned to either group and supplemented daily for six weeks a 1 x 109 CFU 
dosage of  B. infantis35624 (n=8) or placebo (n=9).  Both groups underwent an intensive six 
week swim and resistance training program.  Exercise testing (aerobic/anaerobic swim time trials 
and force plate vertical jump) as well as serum and salivary samples (cytokine and 
gastrointestinal (GI) inflammatory and immune markers) were collected pre, mid (week 3), and 
post (week 6).  Recovery-stress questionnaire for athletes (RESTQ-Sport) was administered at 
baseline and at the end of each training week.  Study data was analyzed by Analysis of 
Covariance (ANCOVA) by time point design with the respective baseline values of each 
dependent variable being the covariate.  The B. infantis35624 group had a significant reduction 
in the anti-inflammatory marker IL-1ra (p = 0.029, ηp2 = .296) and a noted statistical trend for a 
decrease in salivary IgA (p = 0.060, ηp2 = .231) in comparison to placebo at mid-point.  The B. 
infantis35624 group had significantly higher RESTQ-sport values in the sport recovery than the 
placebo group.  B. infantis35624 in Division 1 female swimmers does not directly influence 
exercise performance, but did influence markers of inflammation/immune function as well as 
cognitive outlook during six weeks of exercise training.      







The human gut microbiota contains a diverse bacterial species understood to exert 
numerous physiological functions such as protection against pathogens, barrier effects, 
regulation of energy levels and metabolism, modulation of intestinal motility, and regulation of 
immunity within the entire gastrointestinal (GI) tract [1].  Probiotic bacteria are defined as live 
microorganisms that positively modulate microbiota and health of the host such as the human gut 
microbiota [2].  Probiotic supplementation has been demonstrated to beneficially impact the 
intestinal mucosal barrier and improve GI integrity thus, in turn, strengthening GI immune 
response, reducing mucosal inflammation, and decreasing oxidative stress [3-8].   
Recent findings have shown a specific probiotic strain termed Bifidobacterium infantis 
35624 (B. infantis35624), a subspecies of Bifidobacterium, to beneficially impact the immune 
response by inducing regulatory T cells (Treg), which are designated to better contain reactions 
and limit the aggressive spread of immune responses to other tissues in human models within the 
gut as well as beyond the gut [9-11].  It has been previously reported that 6-8 weeks of B. 
infantis 35624 supplementation increases secretion of Treg cells in the peripheral blood of healthy 
human subjects as well as reduce systemic circulation of pro-inflammatory biomarkers TNF-α, 
IL-6 in clinical patients diagnosed with chronic fatigue syndrome (CFS) an immune-
inflammatory disease [12] [9].   
In addition to these systemic immunomodulatory effects, it has also been demonstrated 
that increased concentrations of Bifidobacterium within the gut, through supplementation, can 
positively affect emotional symptoms in CFS patients such as reducing levels of anxiety and 
improving mood [13].  Moreover, B. infantis35624 supplementation in the animal model has 
been found to positively influence neuronal systems and behaviors pertinent to depression [14].  
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These findings suggest Bifidobacterium and its subspecies B. infantis35624 could play a role in 
gut-brain interactions and provide, through supplementation, a prospective therapeutic 
application for these probiotics in response to various forms of cognitive stress. 
In sports and exercise, it is common for highly trained athletes such as elite swimmers to 
undergo periods (> 1 week) of intensive exercise training made up of repetitive, high volume, 
intense concentrated workloads combined with inadequate periods of physical rest [15].  This 
particular exercise training regimen has been reported to result in an increased susceptibility of 
upper respiratory tract infections, GI symptoms (i.e. nausea, cramps, vomiting), physical 
exhaustion (i.e. fatigue), cognitive stress, and overall reductions in sport performance [16-21].  
These potential undesired outcomes during this intensive exercise training phase are 
hypothesized to occur from increased microtrauma (i.e. injury) to the muscle, GI tract, 
connective tissue, and joints [22, 23].  As a result, these injuries are proposed to initiate a local 
and “whole body” systemic inflammatory response that could attribute to a compromise in 
immune function, decreased exercise performance, and negatively alter mood states [22].       
Thus, the systemic immunomodulatory and cognitive effects observed with 
Bifidobacterium and more importantly B. infantis 35624 supplementation in CFS patients 
presents an interesting finding for athletes like swimmers who participate in chronic, prolonged 
intensified exercise training resulting in potential changes to the GI tract, immune function, 
physical readiness, and cognitive stress.  Therefore, the purpose of this novel study was to 
explore the effects of B. infantis 35624 supplementation in swimmers with respects to systemic 






General Experimental Design.  To determine the effects of B. infantis 5624 on systemic 
inflammatory response, exercise performance, and cognitive stress during an intensified exercise 
training phase, a double-blind, randomized placebo controlled Analysis of Covariance 
(ANCOVA) by time point design was utilized.  The dependent variables for this study included 
markers of inflammation and immune function, multiple measures of exercise performance as 
well as a weekly assessment of cognitive stress-recovery.  Participants who meet the inclusion 
criteria were randomly assigned, via stratified randomization, to ingest either B. infantis 35624 
or placebo.  Supplementation commenced at the onset of designated intensified training phase 
thus requiring baseline measurements to be completed at least 72 hours prior to beginning of the 
study and included all blood and salivary samples, exercise performance testing, and cognitive 
stress-recovery assessment.  Additional blood and salivary samples and exercise testing to 
determine possible inflammation, immune, and performance variations during respective training 
phase was measured again at midpoint (week 3) and immediately upon completion (week 6) with 
the cognitive stress assessment being completed weekly (weeks 1-6).   
Subjects.  Twenty (n=20) Division 1 collegiate female swimmers were recruited to participate in 
this study.  All inclusion/exclusion criteria followed the Groeger et al. 2013 study using B. 
infantis 35624 supplementation in CFS patients which states any participants pregnant or 
diagnosed with a lactose intolerance and immunodeficiency in addition to any previous 
abdominal surgery (with the exception of hernia repair or appendectomy) or reported psychiatric 
illness were excluded from the study [9].  Also, all recruited participants were required to refrain 
from taking any anti-inflammatory medications or antibiotics for the previous month as well as 
throughout the duration of the six week study.  Finally, all participants must also report not 
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having any nutritional supplements (with the exception of a multi-vitamin, vitamin C, vitamin D, 
and iron supplements) and/or ergogenic aids for the preceding one week period.  All participants 
were informed of the study procedures and required to provide a written consent. The study was 
approved through the University’s Human Research Protection Program and Institutional Review 
Board. 
Nutrition and Supplementation.  One week prior to beginning supplementation and training, 
all participants received sport-specific nutrition education by a Registered Dietitian (RD) who is 
a Certified Specialist in Sports Dietetics (CSSD) addressing appropriate nutritional needs 
throughout duration of the study.  Participants then completed a three day dietary food log prior 
to start of the study followed by two additional three day dietary food logs at midpoint and 
immediately upon completion of study.  These recorded dietary food logs were analyzed to 
ensure nutritional habits remained similar as well as each log refraining from foods rich in 
probiotics (ex. Kefir) and caffeine which could potentially influence our findings during the 
course of supplementation and exercise training.           
Subjects began the oral encapsulated supplementation regime of either 1 pill of 4mg (1 x 
109 colony forming units (CFU) live bacteria) B.infantis35624 or an identical encapsulated 
placebo pill consisting of maltodextrin daily throughout their designated six week training phase.  
The B.infantis 35624 supplement is commercially available for purchase and the supplement 
provided to the probiotic subject group was obtained from a local retail store.  The viability of 
the B.infantis 35624 commercial product has been independently tested by ConsumerLabs.com 
verifying the listed amount of probiotic organisms in each capsule does indeed contain 1 x 109 
CFU of live bacteria.   The entire respective supplementation dosage was ingested once each 
day.  To ensure compliance, subjects were blindly provided the supplement each day of practice 
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and were visually observed ingesting their respective supplement by a member of the 
investigative team followed by notation verifying ingestion took place.  On the day(s) 
participants were not required to train each participant received an individual supplement 
container containing their respective pill(s) and instructed to take as directed and return the 
empty container as well as complete a weekly supplement adherence verification form to help 
ensure compliance.   
Intensified Exercise Training Phase.  The designated six week intensified exercise training 
phase was similar for each supplemented group and was coordinated/conducted by the subject’s 
team sport coach and strength & conditioning coach.  Both respective coaches coordinated and 
conducted the subject’s exercise training program during the entire competitive season prior to 
onset of the study.  All subjects received two weeks of physical recovery before the start of the 
study’s training phase which occurred during team’s off-season.  Weeks 1-4 of the intensified 
exercise training included ‘8’ hours of swim training in addition to two – 30 minutes resistance 
training sessions with the accumulative swim practice volume totaling approximately 20 
kilometers each week. Weeks 5-6 the exercise training increased to ‘20’ hours of swim training 
which included within the ‘20’ hrs three– 45 minutes of resistance training sessions with the 
accumulative swim practice volume totaling approximately 40 kilometers each week.   
General Performance Testing.  Subjects underwent exercise performance testing at three 
separate times points (pre, mid, and post) during the designated supplementation and training 
phase.  Testing included a vertical jump test as well as an aerobic and anaerobic swim-specific 
performance assessment.  The vertical jump on a force plate (9260AA6; Kistler Instruments, 
Winterthur, Switerland) using custom-designed software (SpartaTrac; SPARTA Performance 
Science) was completed for all subjects in the morning before the team’s resistance training 
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session in accordance with a standing vertical jump movement to measure rate of eccentric force 
production (N·s-1), concentric force production (N·kg-1), and overall vertical jump height 
(meters) per the team’s specific force plate jump protocol.   
 Overall vertical jump height (meters) was calculated using the impulse-momentum 
relationship (J=∫ F dt=∆p) where the difference in impulse (J) of ground reaction force (JGFR) 
and the impulse of the jumper’s body weight (JBW) determines subject’s jump height [24].  
Eccentric force production (N·s-1) was calculated between the points at which vertical ground 
reaction force exceeds body mass during the countermovement on through to the point of 
minimum displacement of the countermovement  with the reported mean eccentric force 
production calculated between the minimum and maximum force during the eccentric phase 
[25].  Concentric force production (N·kg-1) was calculated 0.001 seconds after the end of the 
eccentric phase to the point of take-off with the reported mean concentric force production 
determined as the average force achieved during the respective phase in relation to body mass 
(N·kg-1). 
The aerobic swim test was a 500 meter freestyle time trial and the anaerobic swim test 
was a 100 meter freestyle time trial.  Each swim test was conducted in a 25 meter training pool 
located in team’s home natatorium.   Both swim tests were standard assessments of exercise 
performance frequently conducted by head coach during the competitive season.     
Blood and Salivary Collection, Systemic and GI Inflammatory/Immune Markers.  In 
accordance with the supplementation and exercise performance testing, blood and salivary 
samples were also obtained pre, mid, and post of the supplementation/intensified training 
experiment.  These samples were collected at rest before the exercise training session as well as 
at the same day and time for each measurement time point.  At each respective time point 5mL 
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of blood was collected from each subject via venous puncture in the afternoon, at rest, and before 
afternoon exercise training occurred that day. To obtain serum samples, all collected blood was 
allowed to clot at room temperature then separated by refrigerated centrifugation and 
subsequently aliquoted and frozen at -80°C for later analyses according to assay procedure 
requirements.  These frozen serum samples were used to measure markers of systemic 
inflammation (IFN-γ, IL-1b, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17, IL-17F, IL-22, 
TNF-α) using a custom luminex magnetic bead-based human cytokine panels A&B (R&D 
Systems, Bio-Techne) as well as markers of GI integrity (endotoxin/LPS and LPS Binding 
Protein (LBP)) using a pierce LAL chromogenic endotoxin quantitation kit (Thermo Scientific) 
and human LBP duoset ELISA (R&D Systems, Bio-Techne).   
Salivary samples using Salimetrics SalivaBio swabs were used to collect and measure 
immunoglobulin A (IgA) immediately following collection of blood/serum samples.  However, 
before subjects provided a blood sample, per Salimetrics instructions, they were required to 
thoroughly rinse out their mouth with tap water and wait 10 minutes before providing a salivary 
sample.  Once ready to provide a sample, subjects were instructed to remove the SalivaBio Oral 
Swab (SOS) from packaging and place, without touching, in their mouth and under the tongue.  
Subjects were required to keep the SOS under their tongue for two minutes to ensure it is fully 
saturated.  After two minutes and full saturation, subjects placed the SOS, by mouth and without 
touching, into the swab storage basket insert located in the swab storage tube which was then 
capped and frozen immediately at -80°C to be later analyzed using a Salimetrics salivary 
secretory IgA indirect enzyme immunoassay kit.      
Cognitive Stress-Recovery Assessment.  A cognitive stress-recovery assessment using the 
Recovery-Stress Questionnaire for Athletes was utilized at the end of each training week to 
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determine the participant’s cognitive outlook during the intensified training study [21].  The 
RESTQ-Sport questionnaire utilized was the short version consisting of 52 items used to assess, 
in a multidimensional way, an athlete’s stress-recovery state during a specific training cycle. 
Each item answered in the RESTQ-52 Sport, which is based on a Likert-type scale with values 
ranging from 0 (never) to 6 (always), indicates how often an athlete participated in certain 
activities during the previous three days and nights.  Once completed each week, these 52 items 
generate 19 specific stress-recovery scales which are grouped into four categories; general stress, 
general recovery, sport stress, and sport recovery in efforts to reflect, quantitatively, each 
supplementation group’s subjective cognitive assessment of stress and recovery during the 
intensified exercise training load.             
Statistical Analyses.  All statistical analyses was performed using SPSS V.22 (Chicago, IL) 
software.  Study data was analyzed by Analysis of Covariance (ANCOVA) by time point design 
with the respective baseline values of each dependent variable being the covariate. The 
dependent variables were defined as the blood and salivary inflammatory/immune markers, 
exercise performance tests, and RESTQ-52 Sport scale scores while the independent variables 
were the supplemented vs non-supplemented groups and time.  Data was considered statistically 
significant when the probability of type I error is ≤ 0.05.  Dietary food logs were analyzed using 
a One-Way ANOVA.  To determine statistical significance of ≤ 0.05 between groups a robust 
test of equality of means using Welch/Brown-Forsythe statistics was utilized due to homogeneity 
of variances being violated because sample sizes were different among the groups.  In addition, 






Study population, supplementation, and nutrition. Seventeen of the twenty recruited subjects 
completed the study.  Two subjects dropped out due to illness while the third subject dropped out 
due to quitting the team.  Therefore, nine subjects in the placebo group and eight subjects in the 
B. infantis 35624 group completed the six week intensified exercise training study.  
Supplementation compliance throughout the study, which included weekends, was 96.94% in the 
placebo group and 97.81% in the B. infantis 35624 group.  Dietary food logs reported no 
statistical difference in total energy calories, carbohydrates, protein, and fat dietary intake 
between the groups throughout the study. 
Swim and force plate performance testing.  Table 1 details the no statistical significant 
difference  observed between supplemented groups aerobic (week 3, p = .485) (week 6, p = 
.762), and anaerobic swim (week 3, p = .700) (week 6, p = .735) performance testing as well as 
their force plate power testing measuring eccentric force production (week 3, p = .666) (week 6, 
p = .961), concentric force production (week 3, p = .613) (week 6, p = .606), and overall vertical 
jump height (week 3, p = .280) (week 6, p = .192).   
Systemic cytokine, GI, and Salivary IgA markers.  Systemic inflammatory markers IFN-γ, IL-
1b, IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17, IL-17F, IL-22, TNF-α were below detectable 
levels and was unable to obtain any values.  IL-1ra in the B. infantis 35624 group had 
statistically significantly lower (p = 0.029, ηp2 = .296) serum levels at mid-training (week 3) in 
comparison to the placebo group (Figure 1).  However, no statistical significant difference 
between groups in IL-1ra levels at post-training (week 6, p = .769) was observed.  Serum GI 
markers endotoxin (LPS) and LBP were also not statistically significantly different between the 
supplementation groups.  A trend towards statistical significance was observed in Salivary IgA 
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levels with B. infantis 35624 group measuring lower (p = 0.060, ηp2 = .231) at mid-training in 
comparison to the placebo group (Figure 2).  However, similar to IL-1ra levels, no significant 
difference was found between groups at post-training (week 6, p = .436). 
RESTQ-52 Sport.  Table 3 shows the summary scores in each stress-recovery scale of the 
RESTQ-52 Sport for all seven measurements (weeks 0-6) taken during the study.  During the 
first four weeks, which encompassed the ‘8’hr training schedule, no statistical significant 
difference was observed between the groups until weeks 3 and 4 with significant changes noted 
within the “General Stress” category under the Conflicts/pressure scale and Social stress scale 
respectively. The B. infantis 35624 supplemented group reported during week 3 of training 
significantly higher values  of Conflicts/pressure in comparison to placebo group (probiotic – 
2.08 ± .97, placebo – 1.67 ± 1.12). Following the conclusion of week 4, B. infantis 35624 group 
had significantly lower values in Social stress in comparison to placebo group (probiotic – 1.00 ± 
.65, placebo – 1.72 ± .51).  During the last two weeks of the study, which required both groups to 
undergo the ‘20’hr exercise training regime, a statistical significant difference was found within 
the “Sport Recovery” category under the Personal accomplishment scale (week 5) and Self-
regulation scale (weeks 5&6).  The B. infantis 35624 group recorded significantly higher values 
in both the  Personal accomplishment (probiotic – 3.43 ± .93, placebo – 2.75 ± .87) and Self-
regulation (Figure 4)  in comparison to placebo group.          
Discussion 
 To the authors’ knowledge, this was the first study to investigate B. infantis 35624 
supplementation in healthy collegiate athletes.  More specifically, to study the effects B. infantis 
35624 supplementation has on exercise performance, inflammation/immune function, and 
cognitive stress-recovery outlook in Division 1 collegiate female swimmers during a six week 
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intensified exercise training phase.  We did not observe any exercise performance differences 
between the supplemented group’s aerobic and anaerobic swim time trials as well as their force 
plate vertical jumps throughout the study.  Similar to our findings, previous studies have also 
been unable to demonstrate probiotic supplementation’s ability to directly affect exercise 
performance supplementing other probiotic bacteria strains and not B. infantis 35624 [19].  
Rather, its effects on exercise performance has been suggested to be more indirect as reported by 
Salarkia et al. 2013 using probiotic yogurt in young adult female endurance swimmers [26].  The 
probiotic yogurt contained several probiotic strains (Lactobacillus Acidophilus, Lactobacillus 
Delbrueckii Bulgaricus, Bifidobacterium Bifidum, and Streptococcus Salivarus Thermnophilus) 
with a total bacteria count of 4 x 1010 CFU and was consumed for 8 weeks.  They found 
swimmers supplemented with the probiotic yogurt had significant improvements in VO2max.  
These VO2max improvements were suggested to be related to reductions in the number of 
occurrences of respiratory infections in addition to the probiotic yogurt supplemented athletes 
being healthier overall during the eight weeks of training.  As a result of the yogurt group 
reporting an enhanced immune function and a reduced susceptibility to illness they suggest the 
probiotics indirectly allowed the athletes to maximize their training benefits during the eight 
weeks of intensive exercise training resulting in a significant increase in VO2max.   
 In the present study, all subjects who completed the six week exercise training were not 
diagnosed, by the team’s physician or physician’s assistant, with any respiratory infections or 
illnesses that kept them out from participation in the study.  The two subjects diagnosed with an 
illness and unable to train for more than several days were removed from the study and not 
included in the analysis.  Since we were unable to find any differences in our exercise 
performance testing throughout the study and did not observe any changes between the groups’ 
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occurrences of respiratory infections, or even trends reflecting the probiotic group to be less 
susceptible to illness, our findings were unable to support a potential indirect effect on exercise 
performance from probiotic supplementation as suggested by Salarkia et al. 2013.         
 According to the results of our study only a significant decrease in the systemic cytokine 
marker IL-1ra within the probiotic group at mid-training was found.  IL-1ra is an anti-
inflammatory cytokine and is a natural antagonist that competes with IL-1β, a pro-inflammatory 
cytokine, for receptor binding without initiating a pro-inflammatory signal transduction [27, 28].  
Significant elevations in IL-1ra levels of up to 40 fold increases have been reported to occur 
following most endurance exercise [29].  Research suggests this increase following endurance 
exercise is in response to the rapid increase of systemic IL-6 concentrations [30, 31].  Since IL-
1ra originates from mononuclear and polymorphonuclear leukocytes as opposed to IL-6 which is 
produced locally from the working muscle during exercise, it is believed the leukocyte derived 
IL-1ra production is significantly increased when the pro-inflammatory production of IL-6 
within skeletal muscle gets released in efforts to exert strong anti-inflammatory effects [31-35].  
Thus, it is suggested the levels of systemic IL-1ra reflect the production of IL-6 [36].  
Unfortunately, we were unable to detect and measure systemic levels of IL-6.  Therefore, we are 
unclear as to why IL-1ra levels during the mid-point of training were lower than placebo.  
However, given previous findings by Groeger et al. 2013 demonstrating reduced systemic levels 
of IL-6 in CFS patients with B. infantis 35624 supplementation it could be speculated similar 
effects occurred in our probiotic supplemented group’s systemic levels of IL-6 during the ‘8’hr 
exercise training regimen [9].  As a result of these “theorized” lowered IL-6 levels during and 
following exercise, it is plausible IL-1ra followed a similar pattern with systemic levels being 
lower after exercise and at rest in comparison to the placebo group. 
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As previously stated, we were unable to detect or even extrapolate the additional 
cytokines and their levels despite obtaining a high bead count for each marker during analysis.  
A previous study has reported IL-1b and IL-5 to be below detectable limits in the serum of 
healthy subjects [37].  However, cytokines IFN-γ, IL-2, IL-4, IL-6, IL-10, IL-13, IL-17, IL-17F, 
TNF-α have been found to be detectable with referenced normative levels in the serum of healthy 
subjects [37].  Therefore, our inability to detect these previously referenced cytokines is possibly 
due to the sensitivity of our antibodies, and the minimum detectable levels using our system with 
resting (i.e. outside of physical exercise) serum cytokine levels in healthy subjects such as highly 
trained collegiate athletes.  
To the author’s knowledge, this is the first study to examine the effects of probiotic 
supplementation on salivary IgA in swimmers during an intensive exercise training phase.  A 
statistical trend, non-significant, reduction in salivary IgA at mid-point of the study was noted in 
the probiotic group.  IgA is the predominant protein in the mucosal antibody response which is 
critical in helping neutralize toxins and remove pathogens [38].  Previous studies have shown 
chronic, prolonged intensive exercise to decrease salivary IgA levels and subsequently increase 
likelihood of developing an upper respiratory tract infection in athletes [39, 40].  This inverse 
relationship between salivary IgA and development of upper respiratory tract infection has been 
reported to occur in marathon runners [41] with salivary IgA secretion being reduced by 10% 
followed by 25% of the runners reporting an upper respiratory tract infection within two weeks 
after completing the race.  As previously stated, there were no respiratory infections or illnesses 
amongst any of our subjects which included all subjects in the probiotic group.  Despite a nearly 
33% reduction in salivary IgA secretion at mid-point in comparison to baseline within the 
probiotic group as well as a noted statistical trend difference in comparison to placebo it did not 
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appear to negatively affect the subject’s immune function and ability complete the required 
exercise training.     
Gut inflammatory markers endotoxin (LPS) and LBP measured no significant difference 
between the groups throughout the study.  To our knowledge this is the first time both GI 
markers have been measured in swimmers undergoing an intensive exercise training phase.  Our 
endotoxin levels measured amongst our group of collegiate swimmers were similar to levels 
reported by Lira et al. 2010 in highly trained cyclists [42].  Lira et al. 2010 found and concluded 
that endotoxin levels correlate negatively with highly trained subjects.  Since our subjects are 
also highly trained we observed a similar correlation despite exercise training being strenuous 
and intensive.  As a result of our endotoxin findings it was not surprising for LBP levels to 
remain unchanged between both the probiotic and placebo groups.  LBP has been previously 
shown to play an important role in the inflammatory response that is secondary to increased 
blood levels of endotoxin [43, 44].  Since we observed no change, or difference, in serum 
endotoxin levels between groups throughout the study then it would almost expected for LBP 
levels to follow a similar pattern. 
Our cognitive RESTQ52-Sport findings suggest the ‘8’ hr exercise training regime 
(weeks 1-4) was not a high enough exercise training load to illicit changes within the reported 
scales of general stress, general recovery, sport stress, and sport recovery.  During those 
respective weeks we only found a couple of single time points (i.e. one week) differences 
between the two supplemented groups and lacked any repeated weekly differences to more 
clearly indicate a potential stress-recovery effect from both the training load and/or 
supplementation.  A similar finding in regards to training load in swimmers using the RESTQ-
Sport has been reported [20].  Gonzalez-Boto et al. 2008 also did not observe any differences 
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within the swimmers stress-recovery scales during exercise training phases that involved overall 
swim distances ranging between 3.2km – 3.9km and total swim durations of each session 
between 87 – 102 minutes.  Interestingly, our ‘8’ hr exercise training week averaged a daily 
overall swim distance of 4km and swim duration of 95 minutes.  Therefore, it appears our weeks 
1-4 exercise training were similar to Gonzalez-Boto et al. 2008 which supports our similar lack 
in findings.  When our subjects transitioned to the ‘20’hr week exercise training phase (weeks 
5&6) which included daily overall swim distance of 6.67km and swim duration of  135 minutes 
we observed the probiotic group to have significantly higher values in both respective weeks 
under the scale of self-regulation which is part of the sport recovery group.  The self-regulation 
scale is defined as the use of mental skills for athletes to prepare, push, motivate, and set goals 
for themselves [21].  Therefore, while undergoing a significantly higher exercise training load 
this cognitive scale suggest the probiotic supplemented group felt they were able to mentally 
push and motivate themselves more than the placebo group.  Gonzalez-Boto et al. 2008 reported 
significant reductions in their swimmer’s sport recovery (being in shape, self-efficacy), sport 
stress (emotional exhaustion, injury), and general recovery (physical recovery) when overall 
daily swim distance 5km and overall swim duration was 137 minutes.  Therefore, this finding 
suggests that if we would have continued to supplement B. infantis35624 for additional weeks 
(ex. 4-6 weeks) while undergoing this high volume ‘20’ hr exercise training load would have it 
been possible for the probiotic group to maintain a higher level of self-regulation resulting in an 
indirect means of enhancing exercise performance based simply upon the probiotic group’s 






 This was the first study to investigate the effects of B. infantis35624 probiotic 
supplementation in athletes such as collegiate female swimmers.  Our findings indicated that 
daily B. infantis 35624supplementation during a six week exercise training phase did not directly 
influence exercise swim performance.  However, the probiotic group reported a reduction in IL-
1ra and noted trend reduction in salivary IgA at mid-point as well as higher reports of sport 
recovery during two weeks of the higher training load.  These findings suggest a potential chance 
for an indirect effect on exercise performance if supplementation duration was extended and B. 
infantis35624 dosage altered.  In regards to dosage, the Groeger et al. 2013 study provided for its 
CFS patients a B. infantis35624 daily dosage of 1 x 1010 CFU for 6-8 weeks and reported 
significant systemic reductions in IL-6 and TNF-α [9].  Our daily dosage was 1/10 of the 
Groeger et al. 2013 study at 1 x 109 CFU.  Therefore, it would be of interest to investigate if a 
higher dosage in an athletic population could have a more profound impact on their systemic 
inflammation and immune function continually throughout a higher training load which could as 
a result, in theory, provide an indirect exercise performance benefit as suggested by Salarkia et 
al. 2013.  Furthermore, it appears the higher exercise training loads observed in weeks 5 & 6 of 
our study was similar to the high volume training phase previously discussed by Gonzalez-Boto 
et al. 2013 study.  Gonzalez-Boto et al. reported numerous undesired changes in their swimmers 
RESTQ-Sport stress recovery scales where our probiotic group during a similar high training 
load reported weekly greater values in self-regulation/sport recovery than the placebo group 
which was significantly lower.  Therefore, it would be of further interest to provide B. infantis 
35624 supplementation for a more extended period of time while these swimmers are undergoing 
more chronic/weekly higher training loads to observe if these initial findings would continue as 
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well as potentially positively influence other stress-recovery categories.  In theory these probiotic 
derived positive cognitive changes could also indirectly enhance exercise performance due to a 
better balance within an athlete’s stress-recovery state.  Therefore, additional research is 
recommended to further investigate the duration and dosage questions in hopes of better 
understanding the potential indirect effects B. infantis 35624 supplementation might have on the 
health and performance of athletes.         
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Table 1 Exercise Performance Testing  
  Week 0 Week 3 Week 6 
  Baseline Probiotic Placebo Probiotic Placebo 
 (n=17)         (n=8)                     (n=9)              (n=8)                     (n=9) 
      
Aerobic Swim (seconds) 452.5 ± 20 443.2 ± 10.2 439.6 ± 10.2 440.8 ± 9.3 439.3 ± 9.3 
      
Anaerobic Swim (seconds) 62.9 ± 2.7 62.2 ± .95 61.9 ± .92 62.3 ± 1.45 62.7 ± 1.23 
      
Eccentric Force (N·s-1) 3244 ± 1598  3202 ± 270 2960 ± 253 2897 ± 310 2872 ± 271 
      
Concentric Force (N·kg-1) 17.7 ± 1.5 17.5 ± 7.8 17.3 ± 7.6 17.4 ± 5.6 17.2 ± 5.4 
      
Vertical Jump Height (m) .34 ± .07 .35 ± .01 .32 ± .01 .35 ± .01 .32 ± .01 
Exercise performance testing week 0 baseline covariate values corresponding to the week 3 and week 6 
measurements taken during the training period.  












Table 2 RESTQ52-Sport cognitive stress-recovery 
  Week 0 Week 3 Week 4 Week 5 Week 6 
Scale Probiotic Placebo Probiotic Placebo Probiotic Placebo Probiotic Placebo Probiotic Placebo 
General Stress 
          
1. General Stress 1.71 ± .48 1.61 ± .82 1.71 ± 1.1 1.72 ± .90 .93 ± .67 1.28 ± .76 1.64 ± 1.3 1.94 ± 1.4 2.29 ± .99 2.44 ± 1.1 
2. Emotional Stress 1.58 ± .58 1.78 ± .67 1.83 ± .93 2.00 ± 1.1 1.08 ± .66 1.78 ± .62 1.75 ± .94 2.1 ± 1.11 2.5 ± 1.1 2.44 ± .68 
3. Social Stress 1.50 ± .87 1.61 ± .55 1.64 ± .85 1.67 ± .61 *1.00 ± .65 1.72 ± .51 1.86 ± .99 2.00 ± 1.2 2.43 ± 1.1 2.33 ± 1.0 
4. Conflicts/pressure 1.75 ± .82 2.44 ± 1.1 *2.08 ± .97 1.67 ± 1.1 1.75 ± .99 2.05 ± 1.3 2.25 ± 1.4 2.22 ± 1.0 3.00 ± 1.1 2.56 ± 1.3 
5. Fatigue 2.00 ± 1.0 1.89 ± 1.3 2.17 ± .93 1.94 ± 1.4 1.42 ± 1.7 1.72 ± .44 2.25 ± 1.7 2.33 ± .75 3.33 ± 1.6 2.44 ± 1.1 
6. Lack of energy 1.92 ± .92 2.22 ± .91 2.50 ± 1.2 1.67 ± .90 1.58 ± 1.1 1.83 ± .50 1.25 ± 1.0 1.78 ± .83 2.25 ± 1.2 2.28 ± .87 
7. Physical complaints 0.75 ± .52 1.39 ± .60 1.42 ± 1.1 1.56 ± .53 0.83 ± .82 1.22 ± .67 1.67 ± 1.3 1.50 ± .79 2.00 ± .89 1.55 ± .77 
General Recovery 
          
8. Success 2.00 ± .63 3.28 ± .83 2.17 ± .75 2.61 ± .74 2.67 ± .93 3.17 ± 1.1 3.25 ± 1.5 2.78 ± 1.1 2.75 ± 1.1 3.11 ± 1.1 
9. Social recovery 3.42 ± .66 4.28 ± .67 2.67 ± .93 3.67 ± 1.0 3.50 ± .32 3.89 ± .70 3.50 ± .89 3.56 ± 1.2 3.33 ± 1.2 3.50 ± 1.3 
10. Physical recovery 1.67 ± .82 2.44 ± 1.0 2.00 ± .77 2.33 ± .79 2.42 ± .97 2.61 ± .89 2.75 ± 1.2 2.50 ± .75 1.83 ± .93 2.39 ± .82 
11. General well-being 2.75 ± 1.3 3.94 ± .68 2.83 ± 1.6 3.17 ± 1.2 3.75 ± .42 3.67 ± .97 3.00 ± 1.4 3.22 ± 1.1 2.83 ± 1.1 3.17 ± 1.3 
12. Sleep quality 3.50 ± 1.3 3.78 ± .67 3.86 ± .56 3.89 ± .65 4.07 ± .89 3.72 ± .75 4.14 ± .75 3.67 ± .79 3.36 ± .99 3.50 ± 1.0 
Sport Stress 
          
13. Disturbed breaks 0.96 ± .39 1.25 ± .80 1.04 ± .57 1.25 ± .73 1.04 ± .83 1.25 ± .72 1.07 ± .66 1.56 ± .60 2.04 ± 1.3 1.86 ± 1.1 
14. Emotional exhaustion 1.64 ± .91 1.75 ± .94 1.64 ± .35 1.78 ± 1.3 1.14 ± .75 1.47 ± 1.1 1.69 ± 1.3 1.81 ± .93 1.68 ± 1.3 2.25 ± .93 
15. Injury 2.32 ± .88 1.86 ± 1.2 2.89 ± .93 2.56 ± 1.4 2.14 ± .75 2.19 ± 1.1 3.04 ± 1.2 2.64 ± .82 3.29 ± 1.2 2.19 ± .87 
Sport Recovery 
          
16. Being in shape 1.75 ± 1.1 2.58 ± .94 2.14 ± .63 2.92 ± 1.4 2.75 ± .60 3.39 ± 1.0 2.68 ± 1.1 2.92 ± .94 2.54 ± 1.1 2.78 ± 1.1 
17. Personal 
accomplishment 
2.54 ± 1.0 3.14 ± .49 2.57 ± 1.1 3.31 ± .99 3.32 ± .93 3.14 ± .95 *3.43 ± .93 2.75 ± .87 2.79 ± 1.2 2.72 ± 1.1 
18. Self-efficacy 1.89 ± 1.1 2.64 ± .87 2.43 ± .70 3.47 ± 1.1 3.07 ± .79 3.44 ± .92 3.25 ± 1.1 3.00 ± 1.0 3.08 ± 1.2 3.08 ± 1.2 
19. Self-regulation 2.35 ± 1.3 3.03 ± .81 2.68 ± 1.0 3.17 ± .98 3.11 ± 1.2 3.17 ± 1.1 *3.54 ± 1.1 3.11 ± .94 *3.46 ± .92 2.89 ± 1.0 
Scores in the different scales of the RESTQ52-Sport corresponding to the seven measures (Week 0-6) taken during the training period. 





















Figure 1 Serum concentrations of IL-1ra in collegiate female swimmers pre, mid, and 
post 6 weeks of exercise training and treatment. Probiotic the B. infantis35624 
supplemented group, Placebo group, PRE week 0, MID week 3, POST week 6; n = 8 (B. 
infantis35624 supplementation), n = 9 (placebo). Values are means ± SD.  There was a 

































Figure 2 Salivary concentrations of IgA in collegiate female swimmers pre, mid, and 
post 6 weeks of exercise training and treatment. Probiotic the B. infantis35624 
supplemented group, Placebo group, PRE week 0, MID week 3, POST week 6; n = 8 (B. 
infantis35624 supplementation), n = 9 (placebo). Values are means ± SD.  There was a trend 
towards significant difference between groups at MID of exercise training and treatment: † P 









































































Figure 3 RESTQ52-Sport weekly self-regulation scores in collegiate female swimmers in 
6 weeks of exercise training and treatment.  The use of mental skills for athletes to 
prepare, push, motivate, and set goals for themselves are assessed by this scale.  RESTQ52-
Sport scale is defined as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more often, 5-very often, 
6-always. Probiotic the B. infantis35624 supplemented group, Placebo group, Week 0-6; n = 
7 (B. infantis35624 supplementation), n = 9 (placebo). Values are means ± SD.  There was a 
significant difference between groups at Week 5 and Week 6 of exercise training and 
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Informed Consent Statement/HIPAA Authorization 
 
The Effects of Bifidobacterium Infantis 35624 on Inflammatory Markers and Exercise 
Performance in Collegiate Female Swimmers 
  
INTRODUCTION 
Kansas Athletics, Inc. and The Department of Health, Sport, and Exercise Sciences at the University of Kansas 
supports the practice of protection for human subjects participating in research. The following information 
is provided for you to decide whether you wish to participate in the present study. You may refuse to sign 
this form and not participate in this study. You should be aware that even if you agree to participate, you 
are free to withdraw at any time. If you do withdraw from this study, it will not affect your relationship with 
this unit, the services it may provide to you, or the University of Kansas. 
 
PURPOSE OF THE STUDY 
The purpose of this novel study is to examine in a double blind, placebo controlled design, whether B.infantis 
35624 probiotic supplementation for six weeks in collegiate female swimmers will significantly affect the 
inflammatory/immune response during an intensified training load subsequently enhancing sport 
performance and cognitive outlook. It is hypothesized B.infantis 35624 supplementation will influence the 
inflammatory response during an intensified training phase and enhance exercise performance as well as 
improve cognitive outlook.  
 
B.infantis 35624 Probiotic Supplement 
The B.infantis 35624 supplement product is named Align.  The Align product has been commercially available 
for years to the general public.  It is not a drug.  It contains only one ingredient which is the B. infantis 35624 
probiotic strain.  This specific probiotic strain is naturally found in healthy human gastrointestinal tissue 
which is how it was first discovered 20 years ago.  Therefore, this supplement does not result in ingesting a 
foreign substance.  No adverse effects have ever been reported in any previous peer-reviewed literature 
using this particular supplement.  The dose described below is the standard recommended dose by Proctor 
& Gamble per supplement facts label.  Funding for this study is being provided by Proctor & Gamble.  Proctor 
& Gamble is the company that makes and manufactures the Align supplement product.   
 
PROCEDURES 
Regardless of your participation status in this research study you will be required to participate in a six week 
intensified exercise training regime which will include exercise training in the Robinson Natatorium as well 
as in the Anderson Family Strength and Conditioning Center.  This team training requirement is in efforts to 
eliminate potential undue influence or pressure to participate in the research study.  Total duration of 
exercise training each week will be approximately 8hrs.  Below is the general weekly schedule of team 























































































In addition to the required six week intensified exercise training regime, if you participate in the 
research study you will be instructed throughout the study to orally ingest an encapsulated dosage of 1 
Billion count of the probiotic B.infantis 35624 or 5g Maltodextrin daily as well as follow the week by week 
procedure requirements to complete the research study as described below.  
 
Week 0 - Each subject will fill out a health history questionnaire to establish they qualify for the 
study, and will sign an informed consent statement.  If agreeing to participate, all subjects will then complete 
a body composition measurement via GE Lunar iDXA technology, be provided supplementation instructions, 
receive sports nutrition education to ensure appropriate dietary intake, and given a three day dietary food 
log to complete. 
 
Week 0 – Three days later that same week, 72 hrs before start of exercise training, all participants 
will return completed dietary food log to be randomized and complete all baseline testing which will include 
the following: a blood sample, RESTQ-Sport Psychology Questionnaire, force plate power test (Anderson 
Center), and Anaerobic (100m prime stroke time trial) and Aerobic (500 meter freestyle time trial) swim test. 
 
Week 1 – All participants will begin the high fatiguing intensified training phase lead by head coach 
and team’s strength & conditioning coach, supplementation, and ending the training week by completing 




Week 2 – Begin week by completing a Week 1 Supplement Adherence Questionnaire to ensure 
supplement is being ingested according to study’s protocol, continue high fatiguing intensified exercise 
training phase and supplementation throughout week followed by completing another RESTQ-Sport 
Psychology Questionnaire at conclusion of training week. 
 
Week 3 - Begin week by completing a Week 2 Supplement Adherence Questionnaire, continue high 
fatiguing intensified exercise training phase and supplementation throughout week followed by mid-point 
testing which include at conclusion of training week collecting a RESTQ-Sport Psychology Questionnaire, 
three-day diet record, blood sample, force plate power test, and anaerobic & aerobic swim test.Week 4 - 
Begin week by completing a Week 3 Supplement Adherence Questionnaire, continue high fatiguing 
intensified exercise training phase and supplementation throughout week followed by completing another 
RESTQ-Sport Psychology Questionnaire at conclusion of training week. 
 
Week 5 - Begin week by completing a Week 4 Supplement Adherence Questionnaire, continue high 
fatiguing intensified exercise training phase and supplementation throughout week followed by completing 
another RESTQ-Sport Psychology Questionnaire at conclusion of training week. 
 
Week 6 -  Begin week by completing a Week 5 Supplement Adherence Questionnaire, complete the 
high fatiguing intensified exercise training phase and supplementation followed by post-study testing which 
includes at conclusion of training week the collection of a RESTQ-Sport Psychology Questionnaire, three-day 
diet record, blood sample, force plate power test, anaerobic & aerobic swim test, and body composition 
measurement. 
 
This study will abide stringently to HIPAA and your personal health information.  All of your blood sample 
analysis results, informed consent, health history questionnaire, and RESTQ-Sport Psychological 
Questionnaire will be securely stored in the Applied Physiology Laboratory.  All GE Lunar iDXA bone and body 
composition measurements will be saved electronically on a password protected DXA computer that 
operates the machine as well as the Kansas Athletics Sports Medicine Electronic Medical Records. 
 
You are volunteering to participate in a study in which your body composition will be assessed using Dual-
Energy X-Ray Absorptiometry, commonly referred to as DXA. This research study involves a procedure that 
uses x-rays.  DXA is approved by the State of Kansas and the Radiation Safety Committee on campus for 
this specific use. The DXA measurements are being made by trained personnel who have received formal 
GE training following installation of the DXA for total body scans.  Dr. Larry Magee, M.D., is a Board 
Certified advisor and medical consultant for the research study and will provide medical assistance and 
supervision for those who voluntarily participate in this study. 
 
The amount of radiation that you will receive from a DXA whole body scan is fifty times less than a chest x-
ray.  The Radiation Safety Officer at the University of Kansas oversees this work and can provide you with 




RISKS    
There is inherent danger in all physical exercise.  You may experience muscle soreness during the six week 
research study.  There is also the possibility of injury to your shoulder, knees, hips or back when performing 
the activities in this study.  You may also experience some bruising or discomfort at the site of the blood 
sampling.  You will be given a 24 hour contact number for study personnel to convey any type of unusual 
discomfort or injury.  This study also involves exposure to x-ray radiation since the GE Lunar DXA is an 
imaging technique that uses two low-dose x-ray beams with different levels of energy to measure bone and 
body composition. The Lunar DXA's x-ray beams use a very small dose of radiation and have been stated by 
GE to be equivalent to the same radiation exposure during a Trans-Pacific flight.  If any female subject is 
pregnant or believes to be pregnant she will not be permitted to undergo a scan.  
 
BENEFITS 
We cannot promise any benefits to you or others from taking part in this research.   
 
PAYMENT TO PARTICIPANTS  
There will be no compensation for participation in this study.  
 
PARTICIPANT CONFIDENTIALITY 
Your name will not be associated in any publication or presentation with the information collected about 
you or with the research findings from this study. Instead, the researcher(s) will use a study number or a 
pseudonym rather than your name.  Your identifiable information will not be shared unless (a) it is required 
by law or university policy, or (b) you give written permission.  Permission granted on this date to use and 
disclose your information remains in effect indefinitely. By signing this form you give permission for the use 
and disclosure of your information for purposes of this study at any time in the future.  All data from this 
study will be destroyed after it has been presented at a scientific conference and/or after it has been 
published in a scientific journal, and after a 7 year period. 
 
INSTITUTIONAL DISCLAIMER STATEMENT   
In the event of injury, the Kansas Tort Claims Act provides for compensation if it can be demonstrated that 
the injury was caused by the negligent or wrongful act or omission of a state employee acting within the 
scope of his/her employment. 
    
REFUSAL TO SIGN CONSENT AND AUTHORIZATION 
You are not required to sign this Consent and Authorization form and you may refuse to do so without 
affecting your right to any services you are receiving or may receive from the University of Kansas or to 
participate in any programs or events of the University of Kansas.  Furthermore, participation or refusal to 
participate will not affect your relationship with Kansas Athletics, respective scholarship agreement, 
standing with the swim team, or academic standing. However, if you refuse to sign, you cannot participate 
in this study.   
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CANCELLING THIS CONSENT AND AUTHORIZATION 
You may withdraw your consent to participate in this study at any time. You also have the right to cancel 
your permission to use and disclose further information collected about you, in writing, at any time, by 
sending your written request to: Dr. Andrew Fry, 1301 Sunnyside Ave., Room 101C. 
If you cancel permission to use your information, the researchers will stop collecting additional information 
about you. However, the research team may use and disclose information that was gathered before they 
received your cancellation, as described above.  
 
QUESTIONS ABOUT PARTICIPATION 
Questions about procedures should be directed to the researcher(s) listed at the end of this consent form. 
 
PARTICIPANT CERTIFICATION: 
I have read this Consent and Authorization form. I have had the opportunity to ask, and I have received 
answers to, any questions I had regarding the study. I understand that if I have any additional questions 
about my rights as a research participant, I may call (785) 864-7429 or (785) 864-7385, write the Human 
Subjects Committee Lawrence Campus (HSCL), University of Kansas, 2385 Irving Hill Road, Lawrence, Kansas 
66045-7568, or email irb@ku.edu.  
I agree to take part in this study as a research participant. By my signature I affirm that I am at least 18 years 
old and that I have received a copy of this Consent and Authorization form.  
_______________________________         _____________________ 
           Type/Print Participant's Name   Date 
 
 _________________________________________    
                               Participant's Signature 
 
Researcher Contact Information 
Aaron Carbuhn                                             
Student Principal Investigator                         
Kansas Athletics, Inc.                            
1651 Naismith Dr.                                    
University of Kansas                             
Lawrence, KS 66045                             
785 864 - 1846   
 
Dr. Andrew Fry, PhD 
Faculty Advisor Principal Investigator 
HSES Dept., 101A Robinson 
University of Kansas 
Lawrence, KS 66045 


































Name ________________________________________________ Date______________ 
Home Address __________________________________________________________________ 
Phone Number _______________________  Email ________________________ 
Birthday (mm/dd/yy)____/_____/_____ 
Person to contact in case of emergency__________________________________________ 
Emergency Contact Phone ______________________  
Gender ________ Age ______(yrs) Height ______(ft)______(in)     Weight______(lbs) 
 
 
A. JOINT-MUSCLE STATUS (Check areas where you currently have problems) 
 
 Joint Areas      Muscle Areas 
 (    )  Wrists      (    )  Arms 
 (    )  Elbows      (    )  Shoulders 
 (    )  Shoulders      (    )  Chest 
 (    )  Upper Spine & Neck    (    )  Upper Back & Neck 
 (    )  Lower Spine     (    )  Abdominal Regions 
 (    )  Hips      (    )  Lower Back 
 (    )  Knees      (    )  Buttocks 
 (    )  Ankles      (    )  Thighs 
 (    )  Feet      (    )  Lower Leg 
 (    )  Other_______________________   (    )  Feet 
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B.   HEALTH STATUS (Check if you currently have any of the following conditions) 
 
(    )  High Blood Pressure   (    )  Acute Infection 
(    )  Heart Disease or Dysfunction  (    )  Diabetes or Blood Sugar Level Abnormality 
(    )  Peripheral Circulatory Disorder  (    )  Anemia 
(    )  Lung Disease or Dysfunction  (    )  Hernias 
(    )  Arthritis or Gout    (    )  Thyroid Dysfunction 
(    )  Edema     (    )  Pancreas Dysfunction 
(    )  Epilepsy     (    )  Liver Dysfunction 
(    )  Multiply Sclerosis    (    )  Kidney Dysfunction 
(    )  High Blood Cholesterol or   (    )  Phenylketonuria (PKU)  
         Triglyceride Levels   (    )  Loss of Consciousness    
(    )  Allergic reactions to rubbing alcohol 
 
* NOTE: If any of these conditions are checked, then a physician’s health clearance will required.  
           
C.   PHYSICAL EXAMINATION HISTORY 
 Approximate date of your last physical examination______________________________ 
  
 Physical problems noted at that time__________________________________________ 
 
 Has a physician ever made any recommendations relative to limiting your level of  physical 
exertion? _________YES __________NO 




D.   CURRENT MEDICATION USAGE (List the drug name, the condition being managed, and the length of 
time used) 
 
         MEDICATION          CONDITION            LENGTH OF USAGE 
_____________________ ______________________________ _________________ 
_____________________ ______________________________ _________________ 
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E.   PHYSICAL PERCEPTIONS (Indicate any unusual sensations or perceptions.  Check if you have recently 
experienced any of the following during or soon after physical activity (PA); or during sedentary periods 
(SED)) 
PA SED      PA SED 
(    ) (    )  Chest Pain     (    ) (    )  Nausea 
(    ) (    )  Heart Palpitations    (    ) (    )  Light Headedness 
(    ) (    )  Unusually Rapid Breathing  (    ) (    )  Loss of Consciousness 
(    ) (    )  Overheating    (    ) (    )  Loss of Balance 
(    ) (    )  Muscle Cramping    (    ) (    )  Loss of Coordination 
(    ) (    )  Muscle Pain    (    ) (    )  Extreme Weakness 
(    ) (    )  Joint Pain     (    ) (    )  Numbness 
(    ) (    )  Other________________________ (    ) (    )  Mental Confusion 
 
F. FAMILY HISTORY (Check if any of your blood relatives . . . parents, brothers, sisters, aunts, uncles, and/or 
grandparents . . . have or had any of the following) 
 (    )  Heart Disease 
 (    )  Heart Attacks or Strokes (prior to age 50) 
 (    )  Elevated Blood Cholesterol or Triglyceride Levels 
 (    )  High Blood Pressure 
 (    )  Diabetes 
 (    )  Sudden Death (other than accidental) 
 
G.   STUDY EXCLUSION CRITERIA (Check if applicable) 
             (    )  Pregnant 
 (    )  Diagnosed Lactose Intolerance 
 (    )  Diagnosed Immunodeficiency 
 (    )  Any Previous Abdominal Surgery (with exception to hernia repair or appendectomy) 
 (    )  Documented Psychiatric Illness 
 (    )  Have taken any anti-inflammatory medications or antibiotics for the previous month 
    









































This questionnaire consists of a series of statements. These statements possibly describe your 
psychic or physical wellbeing or your activities during the past few days and nights. Please 
select the answer that most accurately reflects your thoughts and activities. Indicate how 
often each statement was right in your case in the past few days. The statements related to 
performance should refer to performance during competition as well as during practice. 
For each statement there are seven possible answers. 
 
Please make you selection by marking the number corresponding to the appropriate 
answer. Example: 




... I read a newspaper 
 
0 1 2 3 
 
never seldom sometime    often 
 
X 
4 5 6 
 
more often very often always 
 
 
In this example, the number 5 is marked. This means that you read a newspaper very often in 
the past three days. 
 
 
Please do not leave any statements blank. 
 
If you are unsure which answer to choose, select the one that most closely applies to 




In the past 3 days/nights 
 
1)... 1 watched TV 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
2)... I laughed 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
3)... 1 was in a bad mood 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
4)... I felt physically relaxed 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
5)... 1 was in good spirits 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
6)... I had difficulties in concentrating 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
7)... I worried about unresolved problems 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
8)... 1 had a good time with my friends 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
9)... 1 had a headache 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
10)... I was dead tired after work 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
11)... I was successful in what I did 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
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12)... I  felt uncomfortable 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
13)... 1 was annoyed by others 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
14)... I  felt down 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
15)... I had a satisfying sleep 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
16)... I was fed up with everything 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
17)... 1 was in a good mood 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
18)... I  was overtired 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
19)... I  slept restlessly 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
20)... 1 was annoyed 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
21)... I felt as though I could get everything done 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
22)... I was upset 
0 1 2 3 4 5 6





23)... I put off making decisions 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
24)... I  made  important decisions 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
25)... I felt under pressure 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
26)... parts of my body were aching 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
27)... I could not get rest during the breaks 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
28)... I was convinced I could achieve my set goals during performance 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
29)... I  recovered  well physically 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
30)... I felt burned out by my sport 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
31)... 1 accomplished many worthwhile things in my sport 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
32)... I prepared myself mentally for performance 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
33).. .my muscles felt stiff or tense during performance 
0 1 2 3 4 5 6




  34)... 1 had the impression there were too few breaks 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
35)... 1 was convinced that I could achieve my performance at any time 
0 1 2 3 4 5 6




36)... I dealt effectively with my team-mates' problems 
0 1 2 3 4 5 6




37)... I was in good condition physically 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
38)... I pushed myself during performance 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
39)... I felt emotionally drained from performance 
0 1 2 3 4 5 6




40)... 1 had muscle pain after performance 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
41)... I was convinced that I performed well 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
42)... too much was demanded of me during breaks 
0 1 2 3 4 5 6




43)... 1 psyched myself up before performance 
0 1 2 3 4 5 6




44)... I felt I wanted to quit my sport 
0 1 2 3 4 5 6





45)... I felt very energetic 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
46)... I easily understand how my team mates felt about things 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
47)... I was convinced that I had trained well 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
48)... the breaks were not right at times 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
49)... I felt vulnerable to injuries 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
50)... I set definite goals for myself during performance 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
51)... my body felt strong 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
52)... I felt frustrated by my sport 
0 1 2 3 4 5 6
never seldom sometimes often more often very always 
 
53)... I dealt with emotional problems in my sport very calmly 
0 1 2 3 4 5 6













































o assist you in reaching your goals for fueling athletic performance and to customize a 
nutrition plan for you, it is important to know your current eating habits. On the following 
pages, please write down everything you eat and drink for 3 days. Try to pick 3 days that are 
"typical" of the way you eat. If possible, choose 2 weekdays and 1 weekend day. Do not try to 
change your eating habits during the 3 days of record keeping. 
If you have any questions about completing this form, please contact your sports dietitian at:  
                                                      
                                                    
                                                      
 
Helpful Hints 
Record what you have eaten as soon as possible after meals. This makes it much easier to 
remember what and how much you eat.  Remember the following: 
• Preparation: How was the food cooked? Was it baked, grilled, fried, steamed, or 
baked? Was it fresh, frozen or canned? 
• Portion size: Indicate how much of each food you eat by using cups, ounces, teaspoons, 
or tablespoons, or a "handful" where possible. For meats, estimate the ounces you eat. (A 
deck of cards or a computer mouse is about a 3-ounce portion.) 
• Include the fluids that you drink. List the amounts and the types, and the times that 
you drink them. 
• Include the "extras" or condiments you eat: Do you put cream or sugar in coffee? Is 
your tea sweetened or unsweetened? Do you use ketchup, mustard, mayonnaise, steak 
sauce, or salsa on foods? 
• Be specific: If you eat bread, is it white, wheat, whole wheat, rye, honey wheat 













Date Time Food Item and Method of Preparation Amount Eaten 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    




































Figure 1 – 100m Aerobic Freestyle Swim Time Trial 
 
Figure 1 100m aerobic freestyle swim time trial (seconds) in collegiate female swimmers 
pre, mid, and post 6 weeks of exercise training and treatment. Probiotic the B. infantis35624 
supplemented group, Placebo group, PRE week 0, MID week 3, POST week 6; n = 8 (B. 




































Figure 2 – 500m Anaerobic Freestyle Swim Time Trial 
 
Figure 2 500m anaerobic freestyle swim time trial (seconds) in collegiate female swimmers 
pre, mid, and post 6 weeks of exercise training and treatment. Probiotic the B. infantis35624 
supplemented group, Placebo group, PRE week 0, MID week 3, POST week 6; n = 8 (B. 
































Figure 3 – Force Plate Vertical Jump 
 
Figure 3 Force plate vertical jump (meters) in collegiate female swimmers pre, mid, and 
post 6 weeks of exercise training and treatment. Probiotic the B. infantis35624 supplemented 
group, Placebo group, PRE week 0, MID week 3, POST week 6; n = 8 (B. infantis35624 





























Figure 4 – Force Plate Vertical Jump Eccentric Force 
 
Figure 4 Force plate vertical jump eccentric force (N/s-1) in collegiate female swimmers pre, 
mid, and post 6 weeks of exercise training and treatment. Probiotic the B. infantis35624 
supplemented group, Placebo group, PRE week 0, MID week 3, POST week 6; n = 8 (B. 

































Figure 5 – Force Plate Vertical Jump Concentric Force 
 
Figure 5 Force plate vertical jump concentric force (N/kg-1) in collegiate female swimmers 
pre, mid, and post 6 weeks of exercise training and treatment. Probiotic the B. infantis35624 
supplemented group, Placebo group, PRE week 0, MID week 3, POST week 6; n = 8 (B. 































Figure 6 – Serum Endotoxin (LPS) 
 
Figure 6 Serum concentrations of endotoxin (LPS) in collegiate female swimmers pre, mid, 
and post 6 weeks of exercise training and treatment. Probiotic the B. infantis35624 
supplemented group, Placebo group, PRE week 0, MID week 3, POST week 6; n = 6 (B. 
































Figure 7 – Serum LBP 
 
Figure 7 Serum concentrations of LBP (ng/mL-1) in collegiate female swimmers pre, mid, 
and post 6 weeks of exercise training and treatment. Probiotic the B. infantis35624 
supplemented group, Placebo group, PRE week 0, MID week 3, POST week 6; n = 8 (B. 
































Figure 8 – RESTQ52-Sport Scale – General Stress 
 
Figure 8 RESTQ52-Sport weekly general stress scores in collegiate female swimmers in 6 
weeks of exercise training and treatment.  Subjects with high values describe themselves as 
being frequently mentally stresses, depressed, unbalanced, and listless.  RESTQ52-Sport scale is 
defined as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more often, 5-very often, 6-always. 
Probiotic the B. infantis35624 supplemented group, Placebo group, Week 0-6; n = 7 (B. 
infantis35624 supplementation), n = 9 (placebo). Values are means ± SD.    
       
















































Figure 9 RESTQ52-Sport weekly emotional stress scores in collegiate female swimmers in 6 
weeks of exercise training and treatment.  Subjects with high values experience frequent 
irritation, aggression, anxiety, and inhibition.  RESTQ52-Sport scale is defined as 0-never, 1-
seldom, 2-sometimes, 3-often, 4-more often, 5-very often, 6-always. Probiotic the B. 
infantis35624 supplemented group, Placebo group, Week 0-6; n = 7 (B. infantis35624 
supplementation), n = 9 (placebo). Values are means ± SD.  There was a trend towards 



















































Figure 10 RESTQ52-Sport weekly social stress scores in collegiate female swimmers in 6 
weeks of exercise training and treatment.  High values match subjects with frequent 
arguments, fights, irritation concerning others, general upset, and lack of humor.  RESTQ52-
Sport scale is defined as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more often, 5-very often, 6-
always. Probiotic the B. infantis35624 supplemented group, Placebo group, Week 0-6; n = 7 (B. 
infantis35624 supplementation), n = 9 (placebo). Values are means ± SD.  There was a 
















































Figure 11 RESTQ52-Sport weekly conflicts_pressure scores in collegiate female swimmers 
in 6 weeks of exercise training and treatment.  High values are reached if in the preceding few 
days conflicts were unsettled, unpleasant things had to be done, goals could not be reached, and 
certain thoughts could not be dismissed.  RESTQ52-Sport scale is defined as 0-never, 1-seldom, 
2-sometimes, 3-often, 4-more often, 5-very often, 6-always. Probiotic the B. infantis35624 
supplemented group, Placebo group, Week 0-6; n = 7 (B. infantis35624 supplementation), n = 9 
(placebo). Values are means ± SD.  There was a trend towards significant difference significant 
difference between groups at week 2 († P < 0.10) and a significant difference at week 3 of 































Figure 12 – RESTQ52-Sport Scale – Fatigue 
 
Figure 12 RESTQ52-Sport weekly fatigue scores in collegiate female swimmers in 6 weeks 
of exercise training and treatment.  Time pressure in job, training, school, and life, being 
constantly disturbed during important work, over-fatigue, and lack of sleep characterize this area 
of stress.  RESTQ52-Sport scale is defined as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more 
often, 5-very often, 6-always. Probiotic the B. infantis35624 supplemented group, Placebo 

















































Figure 13 RESTQ52-Sport weekly lack of energy scores in collegiate female swimmers in 6 
weeks of exercise training and treatment.  This score match’s ineffective work behavior like 
inability to concentrate and lack of energy and decision making.  RESTQ52-Sport scale is 
defined as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more often, 5-very often, 6-always. 
Probiotic the B. infantis35624 supplemented group, Placebo group, Week 0-6; n = 7 (B. 
infantis35624 supplementation), n = 9 (placebo). Values are means ± SD.  There was a trend 
towards significant difference between groups at week 1 and 3 of exercise training and treatment: 
































Figure 14 – RESTQ52-Sport Scale – Physical Complaints 
 
Figure 14 RESTQ52-Sport weekly physical complaints scores in collegiate female 
swimmers in 6 weeks of exercise training and treatment.  Physical indisposition and physical 
complaints related to the whole body are characterized by this scale.  RESTQ52-Sport scale is 
defined as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more often, 5-very often, 6-always. 
Probiotic the B. infantis35624 supplemented group, Placebo group, Week 0-6; n = 7 (B. 
































Figure 15 – RESTQ52-Sport Scale – Success 
 
Figure 15 RESTQ52-Sport weekly success scores in collegiate female swimmers in 6 weeks 
of exercise training and treatment.  Success, pleasure at work, and creativity during the past 
few days are assessed in this area.  RESTQ52-Sport scale is defined as 0-never, 1-seldom, 2-
sometimes, 3-often, 4-more often, 5-very often, 6-always. Probiotic the B. infantis35624 
supplemented group, Placebo group, Week 0-6; n = 7 (B. infantis35624 supplementation), n = 9 


















































Figure 16 RESTQ52-Sport weekly social recovery scores in collegiate female swimmers in 6 
weeks of exercise training and treatment.  High values are shown by athletes who have 
frequent pleasurable social contacts and change combined with relaxation and amusement.  
RESTQ52-Sport scale is defined as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more often, 5-
very often, 6-always. Probiotic the B. infantis35624 supplemented group, Placebo group, Week 
0-6; n = 7 (B. infantis35624 supplementation), n = 9 (placebo). Values are means ± SD.  There 
was a trend towards significant difference between groups at week 1 of exercise training and 






























Figure 17 – RESTQ52-Sport Scale – Physical Recovery 
 
Figure 17 RESTQ52-Sport weekly physical recovery scores in collegiate female swimmers 
in 6 weeks of exercise training and treatment.  Physical recovery, physical well-being, and 
fitness are characterized in this area.  RESTQ52-Sport scale is defined as 0-never, 1-seldom, 2-
sometimes, 3-often, 4-more often, 5-very often, 6-always. Probiotic the B. infantis35624 
supplemented group, Placebo group, Week 0-6; n = 7 (B. infantis35624 supplementation), n = 9 

































Figure 18 – RESTQ52-Sport Scale – General Well-Being 
 
Figure 18 RESTQ52-Sport weekly general well-being scores in collegiate female swimmers 
in 6 weeks of exercise training and treatment.  Besides frequent good moods and high well-
being, general relaxation and contentment are also in this scale.  RESTQ52-Sport scale is defined 
as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more often, 5-very often, 6-always. Probiotic the 
B. infantis35624 supplemented group, Placebo group, Week 0-6; n = 7 (B. infantis35624 

















































Figure 19 RESTQ52-Sport weekly sleep quality scores in collegiate female swimmers in 6 
weeks of exercise training and treatment.  Enough recovering sleep, an absence of sleeping 
disorders while falling asleep, and sleeping through the night characterize recovery sleep.  
RESTQ52-Sport scale is defined as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more often, 5-
very often, 6-always. Probiotic the B. infantis35624 supplemented group, Placebo group, Week 
0-6; n = 7 (B. infantis35624 supplementation), n = 9 (placebo). Values are means ± SD.  There 
was a trend towards significant difference between groups at week 1 of exercise training and 






























Figure 20 – RESTQ52-Sport Scale – Disturbed Breaks 
 
Figure 20 RESTQ52-Sport weekly sleep quality scores in collegiate female swimmers in 6 
weeks of exercise training and treatment.  This scale deals with recovery deficits, interrupted 
recovery, and situational aspects that get in the way during periods of rest (e.g., teammates, 
coaches).  RESTQ52-Sport scale is defined as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more 
often, 5-very often, 6-always. Probiotic the B. infantis35624 supplemented group, Placebo 


































Figure 21 – RESTQ52-Sport Scale – Emotional Exhaustion 
 
 
Figure 21 RESTQ52-Sport weekly emotional exhaustion scores in collegiate female 
swimmers in 6 weeks of exercise training and treatment.  High scores are shown by athletes 
who feel burned out and want to quit their sport.  RESTQ52-Sport scale is defined as 0-never, 1-
seldom, 2-sometimes, 3-often, 4-more often, 5-very often, 6-always. Probiotic the B. 
infantis35624 supplemented group, Placebo group, Week 0-6; n = 7 (B. infantis35624 


















































Figure 22 RESTQ52-Sport weekly injury scores in collegiate female swimmers in 6 weeks 
of exercise training and treatment.  High scores signal an acute injury or vulnerability to 
injuries.  RESTQ52-Sport scale is defined as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more 
often, 5-very often, 6-always. Probiotic the B. infantis35624 supplemented group, Placebo 
group, Week 0-6; n = 7 (B. infantis35624 supplementation), n = 9 (placebo). Values are means ± 
SD.  There was a trend towards significant difference between groups at week 6 of exercise 































Figure 23 – RESTQ52-Sport Scale – Being in Shape 
 
Figure 23 RESTQ52-Sport weekly being in shape scores in collegiate female swimmers in 6 
weeks of exercise training and treatment.  Athletes with high scores describe themselves as fit, 
physically efficient, and vital.  RESTQ52-Sport scale is defined as 0-never, 1-seldom, 2-
sometimes, 3-often, 4-more often, 5-very often, 6-always. Probiotic the B. infantis35624 
supplemented group, Placebo group, Week 0-6; n = 7 (B. infantis35624 supplementation), n = 9 































Figure 24 – RESTQ52-Sport Scale – Self-Efficacy 
 
Figure 24 RESTQ52-Sport weekly self-efficacy scores in collegiate female swimmers in 6 
weeks of exercise training and treatment.  This scale is characterized by how convinced the 
athlete is that he/she has trained well and is optimally prepared.  RESTQ52-Sport scale is defined 
as 0-never, 1-seldom, 2-sometimes, 3-often, 4-more often, 5-very often, 6-always. Probiotic the 
B. infantis35624 supplemented group, Placebo group, Week 0-6; n = 7 (B. infantis35624 























Table 1 – Dietary Food Log ANOVA Analysis 
              
 Placebo Supplementation  Probiotic Supplementation  
 Week 0  Week 3  Week 6  Week 0  Week 3  Week 6   
 (n=9)  (n=9)  (n=9)  (n=7)  (n=8)  (n=8)  
              
Total Energy (calories) 1776 ± 445  2069 ± 430  1939 ± 415  2284 ± 536  2454 ± 1064   2540 ± 806   
(min - max) (1076 - 2493)  (1493 - 2727)  (1401 - 2605)  (1742 - 3252)  (1690 - 4996)  (1585 - 4122)   
              
Carbohydrates (grams) 194 ± 63  216 ± 68  215 ± 78  254 ± 92  285 ± 160  297 ± 119   
(min - max) (107 - 282)  (156 - 372)  (125 - 382)  (163 - 438)  (171 - 669)  (178 - 551)   
              
Protein (grams) 105 ± 44  119 ± 45  126 ± 44  130 ± 31  138 ± 52  131 ± 34   
(min - max) (67 - 213)  (62 - 182)  (81 - 216)  (71 - 161)  (97 - 259)  (93 - 187)   
              
Fat (grams) 68 ± 17  84 ± 26  69 ± 21  87 ± 29  93 ± 37  98 ± 35   
(min - max) (34 - 92)  (54 - 136)  (46 - 97)  (55 - 136)  (62 - 169)  (51 - 150)   
 
 
 Significance Between Groups (p-value) 
  Week 0  Week 3  Week 6 
 Robust Test of Equality - Welch 
Total Energy  0.066  0.363  0.087 
Carbohydrates 0.169  0.283  0.126 
Protein 0.201  0.435  0.781 
Fat  0.16  0.569  0.07 
 
